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ABSTRACT

Encapsulation of biomolecules is of great interest to research advances related to biology, physiology,
immunology, and biochemistry, as well as industrial and biomedical applications such as drug delivery,
biocatalysis, biofuel, food and cosmetics. Encapsulation provides functional characteristics that are not
fulfilled by free biomolecules and stabilizes the fragile biomolecules. In terms of biocatalysis, solid
support can often enhance the stability of enzymes, as well as facilitate separation and recovery for reuse
while maintaining activity and selectivity. Various kinds of materials have been used for encapsulation of
biomolecules, among which, porous materials are an important group. Metal-organic frameworks (MOFs)
have attracted much attention and emerged as a new generation of highly porous functional materials with
potential in a variety of fields such as gas separation and storage, catalysis, sensors and biomedical
applications. Their structural versatility and amenability to be designed with specific functionality,
together with their extra-large surface areas confer them a special place amongst traditional porous
materials. In particular, because ligands can be designed with particular organic functional groups for
specific interactions with biomolecules, they are attractive in the stabilization and retention of
enzyme/proteins for biomedical or biocatalysis applications. With enlarged pore sizes, mesoporous (pore
sizes in the range of 2 to 50 nm) MOFs are of great interest in the encapsulation of proteins. In this
dissertation, I am focusing on the encapsulation of biomolecules into mesoporous MOFs (mesoMOFs) to
estabilish the biomolecules@mesoMOF platform, including synthesis, characterization and mechanistic
studies

of

a

series

of

novel

biomolecules@mesoMOF

biomolecule@mesoMOFs platform for various applications.

ix

materials,

and

to

develop

the

A series of hemoproteins, microperoxidase-11 (MP-11), Myoglobin, and Cytochrome c have been
successfully encapsulated into a mesoporous MOF, Tb-mesoMOF, and demonstrated superior catalytic
activities as well as unprecedented size-selective biocatalysis. The kinetic studies revealed enhanced
enzyme stability and boosted enzyme activity upon encapsulation in various solvents.
Mechanistic studies have also been conducted using various instruments for better understanding of
this novel platform, biomolecules@mesoMOF. Fluorescence studies suggested that Cytochrome c
undergoes conformational changes during translocation into the MOF interior through the relatively small
nanopores. A protein transport mechanism that contains the salient features of protein translocation into
cellular organelles has been proposed to interpret the encapsulation process. The Raman studies indicated
strong interaction between the organic ligand and the encapsulated biomolecules. These interactions
facilitated the retention of the small biomolecule inside the pores of MOF, which explained why MP-11
and Cytochrome c can be retained inside the frameworks for a long period without leaching despite the
much larger pore sizes of the MOF. This understanding of the specific interactions between the
biomolecules and the wall of the mesoporous matrix is fundamentally important for development of the
porous materials with improved encapsulation properties and geometries. The diffusion kinetics of
vitamins into Tb-mesoMOFs has also been investigated and the results indicated the fast transportation of
small biomolecules into Tb-mesoMOF.
Besides the investigation of encapsulating biomolecules into mesoMOFs, I also conducted biomimetic
studies on a metal-metalloporphyrin framework, MMPF-6. The biomimetic studies of MMPF-6 illustrated
MOFs as a new type of biomimetic catalyst and also opened up new perspectives for mimicking hemebased proteins.

x

CHAPTER ONE: INTRODUCITON

1.1 Mesoporous Metal-Organic Frameworks
Metal-organic frameworks (MOFs), which are defined as the 2D or 3D coordination polymers
composed of metal moieties and organic linkers, have attracted great attention over the past two decades.
In particular, porous MOFs have emerged as a new generation of highly porous crystalline materials with
potential applications in a variety of fields1 such as gas separation and storage, heterogeneous catalysis,
biocatalytic and biomimetic applications, sensors and biomedical applications. MOFs can be deliberately
designed by pre-selecting the appropriate inorganic (metals or metal clusters) and organic (organic
ligands) building blocks and/or by post-synthetic modifications (PSMs).2 The unlimited choices of metals
and organic building blocks give rise to enormous structural diversity of this family, whose members vary
in metrics and functionalities. According to the classification of IUPAC, the material with pore size
smaller than 2 nm is microporous; pore size ranging from 2-50nm is mesoporous; pore size larger than
50nm is defined as macroporous.3 MOFs can exhibit cavities and/or open channels with a range of pore
sizes from micro- to mesoporous. Compared to microporous MOFs, mesoporous MOFs, hereafter dubbed
mesoMOFs,4 allow for loading of cargos with large dimensions or fast diffusion of large active species,
which dramatically broadens the applications of MOFs, and offer great opportunities for biocatalysis,
sensing and biomedical applications.5 In addition, mesoMOFs have demonstrated thus far the highest
porosity and surface areas which can facilitate the gas storage application, especially under high pressure.
Traditional mesoporous materials, such as mesoporous silica, metal oxides and activated carbon, are
composed of either inorganic or organic compounds, and suffer from intrinsic limitations. Specifically,
1

the inorganic compounds are lack of structural flexibility whereas the organic compounds are usually
amorphous without crystalline structure. MesoMOFs combined inorganic and organic beneficial features
within one system, and their structural versatility, together with amenability to be designed with specific
functionality as well as extra-large surface areas, confers them a special place amongst traditional
mesoporous materials.
1.1.1 Representative structures and examples of mesoMOFs
The adsorption isotherms can be used to determine the size and shape of pores as well as classify
porous materials. Typically, mesoMOFs exhibit type IV and type V isotherm (Figure 1.1) featured with
hysteresis loops (IUPAC classification).6 However, Type I isotherm with secondary uptake platform is
also observed in some mesoMOFs, especially those with the hierarchical structures possess both microand meso-porosity, such as MIL-100 7 and MIL-101.8

Figure 1.1 IUPAC classifications of adsorption isotherms. (Reproduced with permission from Ref 4. ©Taylor & Francis,
2010)

The pores of mesoMOFs refer not only to channels but also cavities (Table 1.1). In terms of the
structures and pore shapes, mesoMOFs can be classified into two types, the channelled and caged
mesoMOFs. Channelled mesoMOFs such as IRMOF-169 and BiO-MOF-10010 possess 1D open mesochannels when viewing the structures along some specific directions. Caged mesoMOFs, such as MIL1007 and-1018, possess polyhedral meso-cavities that are connected by micro-channals or meso-channels.

2

The study of the structural features of mesoMOFs under different catalogs is fundamentally important for
the understanding of principles for the mesoMOFs thus facilitate the development of their properties and
application. In particular, since the determination of crystal structures of MOFs is more accessible than
other porous materials, the pore environments in mesoMOFs are much clearer than ever before. The well
defined cages or channels of MOFs provide detailed information regarding their shapes, sizes, and
chemical environments, which facilate the investigation and control of their morphology, composition,
size and shape when serve as solid support for bio-related applications, and even for the mechanistic
studies in these fields. This will give rise to the understanding and improvements of the basis of
heterogeneous catalyst and microdevice design.
Table 1.1 The representative mesoMOFs and their structural features.

MesoMOFs
MIL-100
MIL-101
IRMOF-16
IRMOF-14
IRMOF-16
mesoMOF-1
Bio-MOF-100
MOF-74-XI
MOF-545
(MMPF-6,
or PCN-222)
NU-1000
JUC-48
CYCU-3
MOF-200
MOF-210
ZIF-95
ZIF-100
NOTT-112
NU-100 (PCN-610)
Tb-mesoMOF
UMCM-1
Bio-MOF-102
Bio-MOF-103
NU-111
DUT-9

Surface area (m2/g)

Structure

BET

Langmuir

type

3100
5900

726
4300
1760
2260

cage
cage
Channel
Channel
Channel
Cage/ Channel
Channel
Channel
Channel

25 and 26
29 and 34
28.8
24.5
24.5
32 and 22.5 × 26.1
28
98
37

MTN
MTN
pcu
pcu
pcu
tbo
lcs
bnn
csq

2320
629
2757
4530
6240
1050

Channel
Channel
Channel
Cage
Cage
Cage

30
21.1× 24.9
28.3× 31.1
18 × 28
26.9× 48.3
25.1× 14.3
30.1× 20
35.6
21
27.4
39 and 47
24 × 29
26
29
24
22 23

csq
etb

4200
1910

1936
1750

595
3800
6143
1783
4160
3222
2704
5000

10400
10400
1240
780
3855
6500

Cage
Cage
Cage
Cage
Channel
Channel
Channel
Cage
Channel

3

Pores size (Å)

Topology

qom
toz
poz
moz
rht
rht
MTN
lcs
lcs
rht

Ref
7
8
9
9
9
11
10
12
13
14
15
16
17
18
19
19
20
20
21
22
23
24
25
25
22
26

(i) Channelled mesoMOFs
There are several groups of examples that represent those mesoMOFs that possess the channel-like
porosity, such as MOF-5 analogue, MOF-545 analogue, MOF-74 analogue, etc.
An example of MOF-5 analogue is the first 3D mesoMOFs, IRMOF-169 (Figure 1.2), which was
reported by Yaghi’s group in 2002. IRMOF-16 is isoreticular to MOF-5, which is of a pcu net built from
the [Zn4O(COO)6] building blocks and triphenyl-4,4’-dicarboxylate (TPDC) ligands. IRMOF-16
possesses a fixed diammeter of 28.8 Å and 91.1% free volume. In addition, the density IRMOF-16 is as
low as 0.21 g/cm3.

Figure 1.2 Illumination of the strategy to synthesize IRMOFs form [Zn 4O(COO)6] building blocks and dicarboxylates ligands.
(Reproduced with permission from Ref 9. © The Royal Society of Chemistry, 2012)

(ii) Caged mesoMOFs
Compare to channeled mesoMOFs, caged mesoMOFs are of particular interest in terms of
encapsulation purpose. There are several groups of examples that represent caged mesoMOFs, such as
rht-mesoMOFs, zeolite-like mesoMOFs, etc.
In 2008, Yaghi’s group reported two novel zeolitic imidazolate frameworks (ZIFs), ZIF-95 and ZIF100, synthesized from 5-chloro-benzimidazole and zinc salts.20 ZIFs can mimic the widely studied SiO2
zeolites since transition metals (Zn and Co) can replace the tetrahedral Si nodes and imidazolate can
replace the oxygen linkers. ZIF-95 possesses a poz topology with four kinds of cages (A, B, C and D).
Among these cages, cage A and B have inner diameters of 25.1× 14.3 Å and 30.1 × 20.0 Å respectively.
ZIF-100 exhibits a moz topology and consists of one unique cage of 35.6 Å inner diameter and 67.2 Å

4

outer diameters. After activation, ZIF-95 and -100 exhibit Langmuir surface areas of 1240 and 780 m2/g
respectively.
In 2004, a polyhedral-based MOFs, MIL-100,7 was reported by Feréy et al. MIL-100 was synthesized
from trimesic acid (H3BTC), metallic Cr, HF in H2O solution. Three Cr centers are linked by one μ3-O
and six carboxylates to form trimer building blocks, which are further connected by three BTC ligands to
form supermolecular building blocks (SBBs) with tetrahedron geometry (Figure 1.3 up). By treating
these SBBs as 4-connected tetrahedral nodes, MIL-100 can be simplified into a zeolitic montmorillonite
(MTN) net. There are two kinds of mesocages constructed by these SBBs via corner sharing mode. The
small cage consists of 20 tetrahedron SBBs and has an internal diameter of ~25 Å. The larger cage is
constructed by 28 tetrahedron SBBs and has an internal diameter of ~29 Å. It is noteworthy that although
these cages are mesoporous, the cage windows are still within micro size range. In 2005, Feréy’s group
reported another mesoMOF, MIL-101,8 synthesized from terephthalates (1,4-BDC), Cr(NO3)3 and
fluorhydric acid in H2O solution. Similar to MIL-100, the Cr trimer building blocks can construct
tetrahedral SBBs, which can also build the MTN net (Figure 1.3 bottom). There are also two kinds of
mesocages constructed by these SBBs via corner sharing mode. The small cage has an internal diameter
of ~29 Å while the larger cage an internal diameter of ~34 Å.

Figure 1.3 Illumination of the structures of cage-base MIL-100 and -101. (Reproduced with permission from publisher ©
American Chemical Society, 2008)
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1.1.2 Strategies for the design and synthesis of mesoMOFs
Currently, mesoMOFs are mainly synthesized by solvothermal method. Microwave-assisted strategy
has also been reported for the fast synthesis of mesoMOFs.27Although this approach is not widely used, it
provides an opportunity for high-speed MOFs synthesis with possible size and morphology control. In
addition, three different strategies have been reported for the design of mesoMOFs: (1) synthesis of
mesoMOFs by extended ligands and bulky secondary building blocks (SBUs); (2) template-directed
synthesis hierarchical mesoMOFs; (3) template-free synthesis hierarchical mesoMOFs.
(i) Synthesis of mesoMOFs by extended ligands and SBUs

Figure 1.4 (a) SBU of MOF 74; (b) SBU with Zn shown as polyhedra of MOF 74; (c) view of crystalline framework with
inorganic SBUs linked together via the benzene ring of 2,5-dihydroxybenzene-1,4-dicarboxylate; (d) ligands used for the
formation of MOF 74 analogs (IRMOF-74-I to XI ) (Reproduced with permission. © American Chemical Society, 2005)

In order to greatly broaden the utility of MOFs, extensive efforts have been devoted to the
investigation of the strategies to enlarge the pore size of MOFs. One obvious approach is to use extended
ligands or bulky SBUs for the construction of mesoMOFs. This has been exemplified by the work of
Yaghi’s group in 2012.12 They synthesized a series of isoreticular structures (IRMOF-74-1 to XI) of
MOF-74 by extending the original MOF-74 linker from one phenylene ring to up to eleven rings (Figure
1.4). With the extended linkers, the pore apertures of these nine IRMOFs have been enlarged ranging
from 14 to 98 angstroms. The extended ligand strategy usually requires multi-steps organic synthesis, and
could be limited by the low stability or the interpenetration of the framework. Several strategies have
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been investigated for the control over interpenetration, such as utilization of oxalate as template, 28
temperature and concentration control,29 liquid phase epitaxy,24 and using sterically bulky groups or
SBUs.30
One example for the bulky SBU strategy was reported by Rosi’s et al..10 They synthesized a mesoMOF,
Bio-MOF-100, by replacing the small 6-connected [Zn4O(COO)6] octahedral building blocks with bulky
zinc-adeninate 6-connected octahedral SBUs. Bio-MOF-100 with the lcs nets exhibits a high surface area
of 4,300m2/g, low crystal densities of 0.302 g/cm and large pore volume of 4.3cm3.g−1 (Figure 1.5, 1.6).

Figure 1.5 Structure and size of the zinc-adeninate building unit (ZABU) (a) compared with the structure and size of the basic
zinc-carboxylate building unit. (Reproduced with permission from Ref 10. ©Nature, 2011)

Figure 1.6 Crystal structure of bio-MOF-100. (Reproduced with permission from Ref 10. ©Nature publishing group, 2011)

Mixed ligand strategy has also been reported to synthesis mesoporous MOFs. UMCM-1 reported by
Matzger’s group is based upon two organic linkers, H2BDC and 1,3,5-tris(4-carboxyphenyl)benzene
(H3BTB) (Figure 1.7).24 Constituted by 1:1.33 ratio of 1,4-BDC:BTB, UMCM-1 features a hierarchical
structure with both micro- and meso-pores. In UMCM-1, six 1,4-BDC and five BTB linkers are
connected by nine [Zn4O(COO)5] to form a microporous cage of 14 × 17 Å. Six such cages are connected
to form a hexagonal meso-channel of 24 × 29 Å. UMCM-1 exhibits the typical type IV N2 sorption
isotherm and demonstrates a high Langmuir surface area of 6500 m2/g.
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Figure 1.7 Structure of UMCM-1: a) A Zn4O cluster coordinated to two BDC linkers and four BTB linkers. Zn4O clusters blue
tetrahedra, C gray, H white, O red. b) A microporous cage constructed ofsix BDC linkers, five BTB linkers, and nine Zn4O
clusters. c) Structure of UMCM-1 viewed along the c axis illustrating the one-dimensional mesopore. (Reproduced with
permission from Ref 24. ©The Royal Society of Chemistry, 2008)

(ii) Template-directed synthesis of hierarchical mesoMOFs
Another widely employed strategy to synthesize mesoMOFs is template-directed synthesis, which has
long been used for efficient synthesis of mesoporous silica. In terms of this strategy, the structuredirecting agent such as surfactants, block copolymers, and swelling agents, is used as the template to
facilitate the formation of mesopores. The surfactant molecules first assemble into micelles and then serve
as the template to direct the formation of porosity of the frameworks during the synthetic process. The
porosity can be influenced and adjusted by synthetic conditions such as reactant concentration, pH,
temperature and the nature of surfactant. Usually, the as-synthesized MOFs are characteristic of
hierarchical structures with both micro- and meso- porosity. In order to create permanent porosity, the
template must be removed after synthesis. The proper strategies for porosity activation are crucial for the
retaining of mesoporosity and the prevention of collapse upon removal of guest molecules. Unfortunately,
the template-directed strategy often suffers from the disintegration of the framework upon removal of the
template molecules that are encapsulated in the crystal lattice.
In 2008, Qiu et al. first applied supramolecular template strategy for the design and construction of
mesoMOFs using cetyltrimethylammonium bromide (CTAB) as the template and Cu2+ and 1,3,5tricarboxylic acid (H3BTC) as the building blocks (Figure 1.8).31 The as-synthesized MOF exhibits
hierarchical structure with adjustable interconnecting micropores and mesopores (Figure 1.9). To further
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enlarged the size of the mesopores, H3BTC was used as an auxiliary structure-directing agent to swell the
surfactant micelles.

Figure 1.8 Mesostructured MOFs self-assembled from metal ions and multifunctional organic ligands in the presence of
surfactant micelles as supramolecular templates. (Reproduced with permission from Ref 31. © Wiley-VCH, 2008)

Figure 1.9 Mesostructured MOFs in which mesopore walls are constructed from micro- or mesoporous MOFs assembled from
metal ions and multifunctional organic ligands. (Reproduced with permission from Ref 30. © Wiley-VCH, 2008)

In 2011, Zhou’s group reported a cooperative template system consist of CTAB as the template and
citric acid (CA) as the chelating agent for the synthesis of a MOF with hierarchical structure. 32 In this
system, CA acts as the chelating agent to bridge the template CTAB and the building blocks, Cu2+ and
H3BTC, during the formation of the MOF in which the walls of the mesopore are constructed by the
surrounded micropores (Figure 1.10).
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Figure 1.10 Cooperative Template-Directed Synthesis of MesoMOFs via Self-Assembly of Metal Ions and Organic Ligands.
(Reproduced with permission from Ref 32. © American Chemical Society, 2012)

Super critical CO2 and ionic liquid can also assist with the surfactant template to facilitate the
formation of mesoMOFs. N-EtFOSA/IL/SCCO2 (N-EtFOSA: N-ethyl perfluorooctylsulfonamide; IL:
ionic liquid; SCCO2: supercritical CO2) system was reported by Zhao et al. to synthesis mesoMOFs with
long-range ordered mesopores.33 First, the surfactant (N-EtFOSA) assembles itself into micelles with the
CO2 molecules inside the core. The building blocks (Zn2+ ions and BDC) in the IL form a crystalline
microporous framework and generate the micro-cavities in the micelles. Finally, after removal of the IL,
CO2, and the surfactant, the MOFs with both mico- and meso- porosity are constructed (Figure 1.11).

Figure 1.11 Formation of the MOFs in the surfactant/ionic liquid/supercritical CO2 system. (a) Formation of N-ethyl
perfluorooctylsulfonamide (N-EtFOSA) cylindrical micelles and (b) MOFs with ordered mesopores and microporous structured
walls (Reproduced with permission from Ref 33. © Wiley-VCH, 2011)

10

(iii) Template-free synthesis of hierarchical mesoMOFs
Very recently, Dai et al. reported a template-free synthesis of a hierarchical mesoMOFs of Zn-MOF-74
of mesopores exceeding 15 nm by fast reaction of Zn salts and H2-DHBDC at room temperature.34 The
surface morphology and porosity of the bimodal materials can be modified by etching the pore walls with
various synthesis solvents for different reaction times. This template-free strategy broadens the
preparation strategies of mesoMOFs, which was previously unattainable in the synthesis of mesoMOFs.
Compared with their micro- or meso-counterparts, mesoMOFs exhibit superior performance, especially
in gas sorption, catalysis and biomedical applications.5 However, up to now, only a small portion of the
reported MOFs are mesoporous. In comparison of microporous MOFs, the synthesis and applications of
mesoMOFs have yet to be systemically and comprehensively developed.

1.2 mesoMOF for Heterogeneous catalysis
The early heterogeneous catalysis study was simply based on metal powders, while highly dispersed
catalytically active components with high-surface solid supports has quickly become the main stream.
Compared to homogeneous system, heterogeneous catalysis possesses a number of beneficial features.
One of the primary aims of applying a catalytically active component to a support is that the catalyst can
be effectively recovered in straightforward manners, such as filtration. Such easy recovery and recycling
is of paramount importance for large-scale industrial and commercial manufacturing process. Moreover,
the support improves the dispersion of the catalyst and thus allows more effective utilization of the
catalytically active component. These features are of especial importance with regard to expensive
catalyst, such as enzymes and precious-metal. The facile separation of catalyst can minimize or eliminate
catalyst contamination and thereby lead to higher purity of the product, which will significantly reduce
the cost of purification process. In addition, the solid support can often protect and stabilize the
catalytically active components under storage and operational conditions, which can be achieved by
suitable interactions between the active component and the support. In this context, heterogeneous
catalysis is the trend for the industrial and commercial application of catalyst.
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Despite these advantages, there are several barriers to be overcome for heterogeneous catalysts.
Generally, the diffusion of the reactant to the catalyst surface can often be the rate-limiting step in
heterogeneous catalysis. The available surface area of the heterogeneous catalyst will potentially limit the
number of available reaction sites, which will also affect the reaction rate. Therefore, materials with high
porosity, large surface area, tunable pore size and accessible structure are highly desirable for the
construction of a proper microenvironment to increase the efficiency of heterogeneous catalysis. Porous
materials with a broad range of pore sizes have been widely investigated as solid supports for
heterogeneous catalysis,35 such as microporous zeolite, mesoporous metal oxide and silica, and
macroporous polymers. MOFs possess some extraordinary properties that are perfectly appropriate for
catalysis application, such as high surface area and porosity, structural versatility and tunable pore size.
Compared to microporous MOFs, the use of mesoporous MOFs as solid catalysts or the support is
significantly interesting because their large pore sizes are favorable for the loading of large catalytically
active components and the diffusion of substrates and products. Moreover, mesoMOFs can be tailored to
create the proper environment around the catalytic active site, which provides the opportunity for chemo-,
regio-, stereo- and/or enantioselectivity that cannot be expected from microporous MOFs. Table 1.2
shows the representative catalysis based on different catalogs of mesoMOFs.
The understanding of catalyst design and the insight into general parameters determining the catalytic
activity, reactivity and selectivity of a catalytic reaction has become the trends of the studies on
heterogeneous catalysis. The rational design of heterogeneous catalyst should consider the essential
attributes of activity, stability, selectivity, and recyclability. In terms of catalyst design, mesoMOFs
provide an excellent platform for studying chemistry and physics of a catalytic process in a confined
space. Since the determination of crystal structures of MOFs is more accessible than other porous
materials, the pore environments in mesoMOFs are much clearer than ever before. Since shape, size, and
chemical environments of the cages or channels of MOFs are well defined, it is possible to investigate and
control their morphology, composition, size and shape of catalytically active particles and the catalyst
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support, and even the interaction between the catalyst and the support. This will give rise to the
improvements in catalytic performance and understanding of the basis of heterogeneous catalyst design.
However, although many remarkable and exciting developments have been achieved on MOFs-based
catalysis over the past 20 years, heterogeneous catalysis based on mesoMOFs is still in an immature
phase and much more territory remains to be explored.
Table 1. 2 Catalogue of known catalytic mesoporous MOFs and summary of reactions catalyzed.

mesoMOF
MIL-101

MIL-101 Supported
Polyoxometalates

Pd/MIL-101
Pd/MIL-101(Cr)–NH2
Ni@MesMOF-1
PCN-100 and PCN-101
CMOFs
MMPF-6(PCN222)

MP-11@Tb-mesoMOF
Mb@Tb-mesoMOF

Substrate(s)
Benzaldehyde
and ethyl cyanoacetate
Tetralin

Reaction(s)
Knoevenagel condensation

Ref.
36

Oxidation

37

Alkenes
Cyclohexane
Epoxides and CO2
Alkene and alcohol

Oxidation
Oxidation
Coupling reaction
Oxidation and epoxidation

38
39
40
41

α-pinene

Oxidation

42

2-Haloanilines
Indoles
p-chloropheno
and aryl chlorides
Styrene or nitrobenzene
Benzaldehyde and 4phenylbenzaldehyde
Aldehydes
1,2,3-trihydroxybenzene
(THB) and 2,2’-azinodi(3ethylbenzothiazoline)-6sulfonate (ABTS)
3,5-di-tert-butyl catechol
THB and ABTS

Cycloaddition
C2 Arylation
Dehalogenation

43
44
45

Reduction
Knoevenagel condensation

46
47

Asymmetric addition
Oxidation

48
14&15

Oxidation
Oxidation

49
50

Heterogeneous catalysis represents one of the earliest applications proposed for MOFs, 51 was
demonstrated around 20 years ago.52 However, along with the construction of the substantial foundation
of the synthetic chemistry of MOFs, it is only recently that the catalytic studies of MOFs have been
dramatically and extensively developed.
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Generally, mesoporous MOFs can serve as the heterogeneous catalyst containing metal active sites or
reactive functional groups, while they can also be utilized as the host matrices for the loading of guest
active species or as nanoscopic reactors.
1.2.1 mesoMOFs as the heterogeneous catalyst
To design a mesoMOFs-based heterogeneous catalyst, several strategies can be used: 1) metal building
blocks in mesoMOFs possess open metal sites as catalytic sites; 2) mesoMOFs can be synthesized using
ligands with reactive functional groups; 3) catalytic species can be grafted to mesoMOFs by postsynthetic modification.
Zhou’s group synthesized two isostructural mesoMOFs, PCN-100 and PCN-101, and demonstrated
their size selective catalytic activity for Knoevenagel reaction of Butyl Cyanoacetate.47 The two structures
was constructed by using [Zn4O(COO)6] as SBUs and two extended ligands containing weakly basic
amine groups, which are preferred by the catalysis of Knoevenagel reaction. PCN-100 and PCN-101
exhibit interesting size- and shape- selectivity towards substrates (Table 1.3).
Table 1.3. Knoevenagel Condensation Reaction of Butyl Cyanoacetate with Substrates Catalyzed by PCNs-100 and -101
(Reproduced with permission from Ref 47. © American Chemical Society, 2010)

Although the heterogenization of chiral catalysis based on porous MOFs has been extensively studied
by several groups,53-55 only a few cases of chiral mesoMOFs catalysis have been reported. However,
homochiral mesoMOFs exhibit impressive catalytic performance towards asymmetric and enantioselective catalysis.
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In 2008, based on the robust R-BINOL-based tetracarboxylate ligand, Lin and co-workers designed two
isostructural mesoMOFs, R-[Cu2L2a(H2O)2]∙12DEF∙16H2O and R-[Cu2L2a(H2O)2]∙16DMF∙19H2O, which
became the first example of chiral mesoMOFs.56 Later on, based on these 4.4-connected networks, Lin et
al. systematically designed a series of isoreticular chiral mesoMOFs with different channels sizes
(CMOFs-2a–4b) (Figure 1.12).48 After functionalization with Ti(OiPr)4, the compounds exhibited
excellent activities towards asymmetric addition of alkylzinc to aldehydes. In addition, by tuning the
channel sizes of the chiral mesoMOFs, the enantioselectivities of these reactions can be adjusted.

Figure 1.12 Schematic representation of a homochiral MOF and its postsynthetic modiﬁcation (PSM) to give a catalytically
active MOF. a, The assembly of CMOFs and their PSM to give heterogenized asymmetric catalysts. b, The chemical structures of
the ligands used for this study. The L1a–L4a and L1b–L4b notations are used to described both the protonated (as in free ligands)
and deprotonated forms (as in CMOFs) of (R)-tetracarboxylic acids. R=Et for CMOF-1a to -4a and R=H for CMOF-1b to -4b.
The primary carboxylic acid groups highlighted in red are used to form CMOFs, whereas the secondary dihydroxy groups
highlighted in blue react with Ti(OiPr)4 on the PSM to form asymmetric catalysts. (Reproduced with permission from Ref 48. ©
Nature publishing group, 2010)

Among catalytic mesoMOFs reported thus far, MIL-101 family has been mostly investigated.
Crystallographically, MIL-101 possesses a rigid zeotype (MTN type) structure, consisting of two different
quasi-spherical cages (2.9 and 3.4 nm), which are accessible through windows of ca 1.2 and 1.6nm
(Figure 1.3).8 With high surface area, high pore volumes, and good solvent/thermal stability (Cr-MIL-101
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up to 300 ◦C), the MIL-101 family can serve as an excellent heterogeneous catalyst or solid support for
various reactions, such as dehydrogenation, oxidation and arylation.
In 2008, Férey and coworkers proposed an efficient strategy for the selective functionalization of the
unsaturated coordinatively unsaturated metal sites (CUS) in MIL-101, which opened the door for the
catalytic studies of MIL-101 family.36 The interior of MIL-101 was modified by chelated chromium (III)
CUS with electron-rich functional groups (Figure 1.13). Using the grafting agents ED and DETA, they
grafted thermally stable amine species in the surface to form the amine-grafted MIL-101, which
demonstrated high catalytic activities in the Knoevenagel condensation model reaction.

Figure 1.13 Site-selective functionalization of MIL-101 with unsaturated metal sites: A) perspective view of the mesoporous
cage of MIL-101 withh exagonal windows; B,C) evolution of coordinatively unsaturated sites from chromium trimers in
mesoporous cages of MIL-101 after vacuum treatment at 423 K for 12 h; D) surface functionalization of the dehydrated MIL-101
through selective grafting of amine molecules (i.e. ethylenediamine) onto coordinatively unsaturated sites; E) selective
encapsulation of noble metals in the amine-grafted MIL-101 via a three-step process. Chromium atoms/octahedra yellow, carbon
atoms pale gray, oxygen atoms red. (Reproduced with permission from Ref 36. © Viley-VCH, 2008)

Kim et al. reported the selective oxidation of tetralin catalyzed by MIL-101 under various conditions.37
The influence of different factors was also investigated, such as different oxidant, solvents, the
substrate/oxidant ratio and the amount of catalysts.
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1.2.2 mesoMOFs as solid support
Park et al. embedded nickel nanoparticles into MesMOF-1 by a two-step strategy.46 The nickelocene
was firstly sublimated into the evacuated MesMOF-1 at 85 ˚C for 1 to 3 h, and then treated with H2 at
95˚C for 5 h (figure 1.14). Three samples (1a,1b, and 1c) were obtained during different loading time (1,
2, and 3 hours), and the TGA analysis revealed enhanced encapsulation of metal nanoparticle along the
increasing loading time. The as synthesized Ni@MesMOF-1 exhibit catalytic activity for the
hydrogenolysis of nitrobenzene or hydrogenation of styrene.

Figure 1.14 A two-step procedure for the preparation of Ni@MesMOF-1 is schematically shown with pictures for the crystals
before and after Ni embedment. (Reproduced with permission from Ref 46. © The Royal Society of Chemistry, 2010)

MIL-101 can be utilized for selective catalysis either as the heterogeneous catalyst or the solid support.
Kholdeeva’s group investigated a serious of MIL-101 supported polyoxometalate-based heterogeneous
catalyst for selective liquid phase oxidation.41
Li et al.43 and Huang et al.44 both encapsulated palladium nanoparticles into the mesoporous cages of
MIL-101 through the wetness impregnation method and investigated their heterogeneous catalytic
performance (Figure 1.15). After their encapsulation into MIL-101 nanoscopic cages, the palladium
nanoparticles exhibit superior catalytic activities and reusability towards both the domino synthesis of
indole and the direct C2 arylation of substituted indoles, which is probably due to the enhancement of
surface hydrophobicity and the the Lewis acid sites in the MIL-101 cages.
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Figure 1.15 The palladium nanoparticles was encapsulated into MIL-101 and exhibit catalytic activity towards the domino
synthesis of indole. (Reproduced with permission from Ref 43. © American Chemical Society, 2011)

1.2.3 Encapsulation of Biomolecules in mesoMOFs
The encapsulation of biomolecules is one of the most common phenomenons in our planet. Without the
formation of cells (the basic biologic units of life), which is a combination of biochemistry and
bioencapsulation, the world would never have the chance to witness the flourishing of enormous variety
of creatures. On the other hand, human is of a long history using techeniques involving the encapsulation
of biomolecules for various purposes. Using bioencapsulation for food preservation can be tracked back
to ~1600 years ago. Encapsulation of biomolecules is of great importance and interest not only to research
advances related to biology, physiology, immunology, and biochemistry, but also contribute to industrial
and biomedical applications such as drug delivery, biocatalysis, biofuel, food and cosmetics as well as the
design and operation of microdevices, such as biosensors. Encapsulation provides functional
charateristics that are not fulfilled by free biomolecules: 1) The confined space facilitates to modulate the
biomolecules precisely; 2) provide a protective environment to the changes in the operating parameters; 3)
provide the proper space and distance for synertistic action of biomolecules. In addition, for the
mechanistic and biomimetic studies, optimized encapsulation may mimic the nature mode of occurnce
inside the cells and provide detailed information that cannot easily achieved in vivo studies.
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Various kinds of materials have been used for encapsulation of biomolecules: polymer, hydrogel, solgel, liposome, solid beads, silica, chitosan, PLGA, etc., and the criteria to evalutate these materials is
highly depended on the purpose of usage. For example, as drug delivery vector, other than the high
loading capacity, control matrix degradation and drug releasing, high biocompatibility and low
cytotoxicity is also required. While for biocatalytic application (heterogeneous catalysis), high loading,
tunable pore size, easy surface modification and functionalization is very important.
Because of the connection with reduced energy consumption, waste generation, and greenhouse gas
emissions, biocatalysis has currently attracted a broad and increasing interest in areas as diverse as
chemical, pharmaceutical, food, and energy production.57 Biocatalysis not only possesses features such as
high efficiency, high stereo-, chemo-, and regioselectivity, but is also environmental friendly.58 However,
the high cost, highly restricted reaction conditions, and the fragile nature of free enzymes handicaps their
industrial application. One of the biggest challenges in the industrial development of biocatalysis is to
enhance the enzyme stability in organic solvents and to increase their endurance under harsh reaction
conditions. The immobilization of the biocatalysts on solid supports provides a feasible and efficient
solution to surmount these problems. Enzyme immobilization can improve the thermal and environmental
stability and insolubilize the enzymes for recovery and recycling and, thus, eases the burden of biocatalyst
cost. The solid support often broadens the applicable pH range of biocatalysts, and protects/stabilizes the
enzyme from denaturing by organic solvents, high temperature or autolysis. In addition, enzyme
immobilization simplifies the overall design and performance control of the bioreactors. Therefore,
industrial or commercial applications of biocatalysts depends on the development of effective methods of
immobilization.59 Among the various types of immobilization methods, encapsulation exhibits advantages
such as enhanced stability, controllable arrangement, and reduction of excessive denaturing.
An approach that continues to be more widely explored is the immobilization of enzymes in ordered
mesoporous materials. Since Balkus and Dίaz first published their work on the immobilization of proteins
in ordered mesoporous materials in 1996,60 extensive efforts have been devoted to develope suitable
mesoporous matrixes and optimize the immobilization conditions. In this context, mesoporous silica
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materials have been systematically and widely investigated, owing to the high surface areas with tunable,
uniform pores. However, the leaching of immobilized catalysts from mesoporous silica leads to great
decrease of enzyme activity upon reuse, which is one of the biggest challenges for the further application
of these materials. This leaching is probably due to the lack of specific interactions between the
biomolecule and the mesoporous silica support.
Mesoporous MOFs can play an irreplaceable role in the development of heterogeneous biocatalysis
due to their structural specificities: i) the high porosity and surface area ensure the high loading and easy
accessibility of catalytic active site; ii) the nanoscale and tunable pore size provides the possibility of
encapsulation of biomolecules; iii) the relative large pores facilitate the ingress and diffusion of substrates
and products. In particular, the large cage of mesoMOFs can be decorated with particular organic
functional groups for specific interactions with biomolecules to prevent leaching, which makes them
attractive to immobilize and stabilize proteins, vitamins, or drugs for biomedical or biocatalysis
applications. Ion exchange and post synthetic modification of mesoMOFs giving rise to even broader
applications. In addition, when an enzyme is encapsulated inside a confined space, the catalytic
performance and behavior can be often distinguished from its free state. In terms of biocatalysis, many
interesting phenomena have been observed during the heterogeneous catalytic process of immobilized
enzyme.61-63 Therefore, the studies on enzyme encapsulation by mesoporous solid supports are of
fundamental importance for the understanding of mechanisms and transport phenomena during the
catalysis process. The well-defined pore structure makes mesoMOFs a perfect research platform in this
field. A rationally designed protocol for mesoMOF-based biocatalysis is usually composed of multiple
steps: 1) synthesis of mesoMOFs with suitable pore size, structure and stability; 2) selecting suitable
enzymes with proper dimensions and interaction with mesoMOFs; 3) encapsulation of enzymes into
mesoMOFs with high loading and stability; 4) selecting suitable test reaction and right substrates for the
catalytic evaluation; 5) mechanistic studies.
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1.4 Conclusion
Although tremendous progress has been achieved in the research field of mesoMOFs, the synthesis and
application of MOFs are still dominated by microporous MOFs. However, along with further
understanding of the basics and principles in the design of mesoMOFs and the development of crystal
engineering and reticular chemistry, an increasing number of mesoMOFs with attractive properties are
constructed through various strategies. With the enlarged pore size, mesoMOFs can remarkably expend
the utilities of MOFs in a wide range of fields, and offer enormous opportunities for applications such as
gas storage and separation, heterogeneous catalysis, biocatalysis, sensing, and drug delivery. In addition,
with the extraordinary advantages of mesoMOFs, great progress and breakthroughs in developing them as
multifunctional materials will be expected in the near future. As with all of the emerging materials, there
are also challenges and barriers to be overcome for further development of mesoMOFs, such as the
improvement of activation strategies, the stability, and the mechanical strength. With the substantially
increasing interest and continuous efforts towards mesoMOFs from both academia and industry, this class
of prospective materials will remain at the forefront of the materials research and play important and
irreplaceable roles in the development of porous materials and their future applications.
As an emerging material for the encapsulation of biomolecules, mesoMOFs possess some extraordinary
advantages compare to other porous materials: the high surface area is favorable for high loading
efficiency; the pore walls composed of functional organic groups may provide specific interactions with
biomolecules, which is preferred for control releasing; the tunable pore size can accommodate broad
spectrum of guest molecules; their accessible crystal structure can serve as a well characterized platform
for the mechanistic studies, such as diffusion and other transport phenomena during encapsulation.
However, in the meantime, this burgeoning research field is still in its infancy stage, and many challenges
need to be overcomed: the optimization of the conditions for biomolecule loading; construction of
mesoMOFs; the water stability and biocapatibility, etc. The objective of my Ph.D. research is the
synthesis, characterization and mechanistic studies of the encapsulation of biomolecules into mesoMOFs
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(biomolecule@mesoMOFs), and to develop the biomolecule@mesoMOFs platform for various
applications, especially for heterogeneous biocatalysis.
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CHAPTER TWO: BIOMOLECULE@mesoMOF AS A NEW PLATFORM
FOR BIOCATALYSIS

Note to Reader
Portions of this chapter have been previously published in J. Am. Chem. Soc., 2011, 133:10382-10385;
Inorg. Chem., 2012, 51, 9156-9158, and have been reproduced with permission from ACS Publishing.

2.1 Background

2.1.1 Tb-mesoMOF
Lanthanide metal-organic frameworks (Ln-MOFs) continue to attract an escalating attention in the
MOF research area owing to their unique optical, magnetic properties and characteristic coordination
preferences of lanthanide metal ions and related clusters. Compared with first-row transition metal ions,
they usually exhibit high coordination number and connectivity, which could facilitate the formation of
stable three-dimensional networks. The lanthanide-based luminescence has been of intense interest over
decades. Compared with the discrete molecular lanthanide complexes, Ln-MOFs are attractive because of
their high surface area, high thermal stability and high luminescence output. Ln-MOFs are also promising
candidates for heterogeneous catalysis application since lanthanide ions have a flexible coordination
sphere and can create coordinatively unsaturated metal centers, and the high surface areas of them
represent another advantage benefiting their catalytic performances. The permanent porosity together with
tunable pore sizes of Ln-MOFs affords them potential for applications in the enpasulation of biomolecules.
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Indeed, over the past decade, remarkable amount of efforts has been dedicated to developing porous LnMOFs as a type of multifunctional materials for various applications. 1
A recently reported2 lanthanide mesoporous MOF, Tb-mesoMOF, was selected as the solid supporting
matrix in this project for the encapsulation of enzymes, due to its mesoporous cavity, good water stability
and easy preparation with relative high yield. In addition, since Tb-mesoMOF is a colorless cystal, it is
easy to track and observe the encapsulation of colorful guest molecules in this system. Tb-mesoMOF is
formed by TATB ligands and Tb4 moieties. Similar to MIL-100, four Tb4 moieties are linked by four
TATB to form a tetrahedral supermolecular building block (SBB). These tetrahedral SBBs are further
interconnected to form a three-dimensional network with the MTN topology. There are two types of
nanoscopic cages: (i) small cages are of a 3.9 nm diameter surrounded by 20 SBBs and with 12
pentagonal windows; (ii) large cages are of a 4.7 nm diameter defined by 28 SBBs and with 12
pentagonal and 4 hexagonal windows.

(e)

(f)

Figure 2.1 (a) TATB ligand. (b) Truncated supertetrahedron in Tb-mesoMOF. (c) MTN topology of Tb-mesoMOF. The two
types of cages are highlighted in green and pink. (d) A 3.9 nm diameter cage and a 4.7 nm diameter cage interconnected through
1.3 and 1.7 nm windows in Tb-mesoMOF. Color scheme: C, gray; O, red; N, blue; Tb, turquoise. (e) The scheme for the small
and large cages in the structure of Tb-mesoMOF. (f) The picture of Tb-mesoMOF crystal.

2.1.2 Heme and Hemoproteins
Heme (heam) is a group of chemical compounds that possess prosthetic group consisting of Fe2+ ion in
the centre of a highly hydrophobic, planar, porphyrin ring, that form four pyrrolic groups joined together
by methine bridges. Heme cofactor is one of the most ubiquitous and functionally diverse cofactors in
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nature, which plays important roles in energy transduction,3 lipid synthsis,4 gene regulation,5 oxygenbinding and transport6 and cellular signaling,7 etc. In the heme structure (Figure 2.2c), the iron has six
possible coordination bonds, and four of them are binding to 4 nitrogen atoms from porphyrin ring,
leaving two other coordination positions of the iron available for binding. The most common heme is
protoporphyrin IX iron (II). As one of the most versatile protein cofactors, 8 heme can bound to proteins
either covalently or noncovalently. Those proteins have heme as their prosthetic groups are known as
hemoproteins. Hemoprotins are involved in various life process, such as oxygen transfer (hemoglobin and
myoglobin),6 cell respiration (cytochromes),3 biotransformations (peroxidases and cytochrome P-450)9 or
sensors (FixL or CooA).5 In addition, hemoproteins are able to catalyze a large range of reactions. For
example, due to heme-dependent activation of iron-bound dioxygen, cytochromes P450 can catalize a
broad repertoire of reactions, including hydroxylation, epoxidation, demethylation and carbon-carbon
bond cleavage.10, 11 Their capabilities to carry out such diverse reactions are greatly depended on the
protein environment of the heme center. In addition, the wide variety of heme axial ligands is also critical
to the modulation of iron reduction potential in heme cofactor, which enables hemoproteins to participate
in the desired reactions. During catalytic cycles, these heme axial ligands may be replaced by other
ligands, such as internal amino acid sidechains of certain hemoproteins or external molecules to facilitate
required reactivity. Basically, the modulation of heme iron reduction potential is attributed to the change
of protein environment as well as the variations of heme axial ligands. Hemoproteins are among the most
arractive and studied classes of biomolecules due to their diverse range of biological functions.

(a)

(b)

(c)

Figure 2.2 (a) Porpyrin. (b) Protoporpyrin IX. (c) Heme.
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In this project, my research mostly focuses on three biomolecules (Figure 2.3), microperoxidase-11
(MP-11), myoglobin (Mb), and cytochrome c (cyto c). These biomolecules all possess heme active center
with excellent water solubility, indicative color and clear spectrum for easy tracking by observation or
UV-vis spectroscopy. Their dimensions fall into the range of ~2-4 nm, which are suitable for the
encapsulation studies in mesoMOFs.

(a)

(b)

(c)

Figure 2.3 (a) Microperoxidase-11(MP-11). (b) Myoglobin. (c) Cytochrome c.

Microperoxidase-11(MP-11) (Figure 2.3a) is a hemepeptide comprising a eleven-residue polypeptide
chain attached to the heme active center, which is one of four kinds of microperoxidases:
microperoxidase-6 (CAQCHT), -8 (CAQCHTVE), -9 (KCAQCHTVE) and-11 (VQKCAQCHTVE). MP11 is usually extracted from the proteolytic digestion of cytochrome c.12 MP-11 possess the heme moiety
(ferric protoporphyrin IX), which covalently linked to the polypeptide chain (to two cysteine residues,
Cys-14 and Cys-17) by thioether bridges. As an important structural feature of MP-11, the imidazole
group of histidine (His 18) occupies the 5th coordination position of heme iron, but the 6th coordination
position of heme is not occupied by methionine. The absence of methionine sulfur allows this site to be
occupied by various ligands.13 For example, the 6th coordination position is weakly occupied by water
molecule in aqueous solution (near pH 7). In a biocatalysis reaction, this water can be easily substituted
by a substrate. It is noteworthy that without the complete protein moiety, the heme center of MP-11 is
exposed to the solvent. All these interesting features entitle MP-11 an interesting model “micro-enzyme”
for the investigation of biocatalysis.
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Myoglobin (Mb) is a monomeric protein that has globular structure with a single-chain of 153 or 154
amino acids (Figure 2.3b). As a typical hemoprotein, myoglobin possesses a heme prosthetic group that is
wrapped around by eight alpha helices, and this “pocket” provides a hydrophobic core. Myoglobin is
called “the hydrogen atom of biology”.14 As the primary oxygen-carring pigment of muscle, myoglobin
exists in almost all mammals and gives muscles their red color.15 As a classic model biomolecule,
myoglobin is one of the most studied proteins in biology. Its relative small size, compact structure,
extensively accumulated biochemical and biophysical characterization is favorable for our project.
Moreover, Mb was the first protein to have its 3D structure revealed by X-ray crystallography.16 However,
the critical physiological functions myoglobin played in biological processes is not yet conclusively
established.
Cytochromes are usually present in the mitochondria and in the endoplasmic reticulum, and they are
well known to play significant roles in the electron transfer process. Cytochrome c (Figure 2.3c) is a
nearly spherical basic protein with the dimensions of ∼2.6 nm × 3.2 nm × 3.3nm. The protein consists of
a single polypeptide chain of 104 amino acid residues.17 Similarly to MP-11, cytochrome c contains a ctype heme that is covalently attached to the polypeptide chain via the two cysteine residues. The iron in
heme center can switch between the ferric (Fe3+) and the ferrous (Fe2+) state, thus acting as a singleelectron carrier. Cytochrome c can also catalyze several different kinds of reactions, such as
hydroxylation and aromatic oxidation, and shows peroxidative activity.

2.2 Synthesis, Characterization and Biocatalytic Studies of MP-11@TbmesoMOF

2.2.1 Introduction
Enzymes are nature’s catalysts, featuring high reactivity, selectivity, and specificity under mild
conditions.18 Enzymatic catalysis has long been of great interest to chemical, pharmaceutical, and food
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industries.19 However, the use of enzymes for industrial applications is often handicapped by their low
operational stability, difficult recovery, and lack of reusability under operational conditions.20
Immobilization of enzymes on solid supports can enhance enzyme stability as well as facilitate separation
and recovery for reuse while maintaining activity and selectivity.21 In this content, extensive attention has
been paid to immobilizing enzymes into mesoporous silica materials that offer high surface areas with
tunable, uniform pores.20,21 Nevertheless, due to the lack of specific interactions with enzyme molecules,
mesoporous silica materials suffer from leaching of the immobilized enzyme during the reaction process,
which in return results in loss of activity upon reuse.20,21 Although postsynthetic modification of pore
walls with functional organic groups, which can provide specific interactions with the immobilized
enzymes, has been widely pursued as a strategy to prevent leaching, this inevitably leads to signifcant
decrease of enzyme loading and/or blockage of the channels.21 Several attributes have been delineated for
an ideal host matrix: (i) a hierarchy of pore sizes including large pores for enzyme ingress and small pores
to allow diffusion of reactants and products, (ii) high surface area to ensure a high enzyme loading, (iii)
large cages decorated with functional organic groups that interact with enzyme molecules and prevent
leaching, and (iv) sustained framework integrity under typical reaction conditions.21 Over the past decade,
a new type of porous materials, porous metal-organic frameworks (MOFs), has emerged.22 Their
amenability to be designed with specific functionality together with their extra-large surface areas not
only makes them stand out of traditional porous materials,23 but also promises great potential for
applications such as gas storage/separation,24sensor,25 magnetism,26 and catalysis.27 That their nanoscale
features can be decorated with functional organic groups for specific interactions with biomolecules
makes them appealing to stabilize enzymes for catalytic applications.28 Although small catalytically active
guest species such as organometallic compounds29 and metalloporphyrins30 have been successfully
encapsulated into porous MOFs, the micropore size of most MOFs precludes the entry of larger-sized
enzymes and could result in only surface adsorption.31 Nevertheless, recent advances in mesoporous
MOFs32 may provide opportunities for enzymatic catalysis. In this project, I demonstrated the successful
immobilization and characterization of microperoxidase-11 (MP-11) into a mesoporous MOF, and the
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resulting MP-11@mesoMOF exhibits superior enzymatic catalysis performances compared to the
mesoporous silica counterpart. MP-11 has dimensions of ~3.3 ×1.7× 1.1 nm.33 It consists of an iron-heme
group linked with an R-helical undecapeptide chain via two thioether bonds of cysteine residues and a
coordinated histidine residue at an axial position of the Fe(III)-heme center (Figure 2.4a). It is able to
oxidize a wide range of organic molecules using hydrogen peroxide.34 The mesoporous MOF we selected
for MP-11 immobilization was a recently reported porous MOF,2 Tb-TATB (hereafter denoted TbmesoMOF), which contains nanoscopic cages of 3.9 and 4.7 nm in diameter (Figure 2.4b,c). It exhibits
characteristic type-IV N2 sorption isotherms (Figure 2.6a) with pore sizes dominantly distributed around
3.0 and 4.1 nm in addition to a small portion of micropore size around 0.9 nm (Figure 2.6b). These
nanoscopic cages provide adequate space to accommodate MP-11, which should be able to enter TbmesoMOF through the mesopores of 3.0 and 4.1 nm.

Figure 2.4 (a) Molecular structure of MP-11 (obtained from the solution structure of PDB 1OCD); (b) 3.9 nm-diameter cage, and
(c) 4.7 nmdiameter cage in Tb-mesoMOF

2.2.2 Experimental Section
(i) Synthesis of Tb-mesoMOF
Crystalline samples of Tb-mesoMOF were prepared according to the procedures reported in ref. 2.
Tb(NO3)3⋅5H2O (0.030 g, 6.90 x 10-5 mol) and 4,4’,4”-s-trizaine-2,4,6-triyltribenzoic acid, H3TATB
(0.010 g, 2.27 x 10-5 mol) was dissolved in a DMA/MeOH/H2O (2.0 / 0.4 / 0.1 mL) in a 20 mL vial at
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ambient temperature. The reaction mixture in a capped vial was heated in an oven at 105 ºC for 2 days.
Colorless truncated octahedral crystals were obtained with the yield of 44.6 % based on the 1.0 mol of
H3TATB.
(ii) MP-11 uptake experiments
To immobilize MP-11, freshly synthesized Tb-mesoMOF crystals were immersed in MP11(SigmaAldrich) solution of HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffer, and
placed in an incubator at 37°C. The supernatant was scanned at different time points to determine uptake
of MP-11 by the decrease of the Soret band at 400nm (ε=176 mM-1cm-1),35 and a saturation was found
after 50 hours. For MCM-41 (SigmaAldrich), the same procedures and conditions were followed using
MP-11 and incubation time of 97 hours to achieve saturation. For each preparation, a sample of the initial
MP-11 solution was also incubated under the same conditions and was used to determine the reference
concentrations and spectra. The saturated samples (hereafter denoted MP-11@Tb-mesoMOF)were then
washed with fresh HEPES buffer solution several times till the supernatant became colorless to fully
remove the surface adsorbed MP-11.
(iii) Examination of the catalytic activities:
The initial rates of oxidation of DTBC by various catalysts discussed in this work (~2.0 mg) in the
presence of 10 mM H2O2 in methanol solution were determined on a Varian Cary50 spectrophotometer.
The oxidation of the substrate to the corresponding o-quinone dimer product was directly monitored at
420 nm (ε=1,910 M-1cm-1)36 by taking the absorption spectra of the supernatant solution at various time
points in the reaction.
Very dilute solution of MP-11 (0.6 µM) in HEPES buffer instead was used to check the optimal
catalytic activity of MP-11 under the same catalytic conditions as above since MP-11 is insoluble in
methanol.
(iv) Single-Crystal Specular Reflectance Spectroscopy
Single-crystal UV-Vis absorbance spectra were obtained with a polarized specular reflectance
microspectrophotometer.37 Single crystals of MP-11@Tb-mesoMOF (about 0.1 mm on a side) and pure
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Tb-mesoMOF (about 0.1 mm on a side) were mounted on glass fibers with Ducocement, the fiber in turn
on a mounting pin and affixed in a standard X-ray gonoimeter head. The natural, reflective crystal
surfaces were oriented normal to the incident light in the spectrophotometer. The light source was a 75-W
xenon arc lamp and all instrument optics is reflective except the polarizer. The reflected light was
collected with a cooled CCD and compared to that from a standardized mirror and then processed into
absorbance data through Kramers-Kronig transformations.38
(v) N2 sorption experiments
N2 sorption isotherms of Tb-mesoMOF and MP-11@Tb-mesoMOF were collected using the surface
area analyzer ASAP-2020. Before the measurements, the freshly prepared samples were thoroughly
solvent-exchanged with methanol, and activated under dynamic vacuum first at room temperature
overnight and then at 120 °C for two hours. The surface area of Tb-mesoMOF is comparable with that
reported in ref. 2 for the sample activated at 80 °C.

2.2.3 Result and Discussion
The uptake of MP-11 by Tb-mesoMOF (Elemental analysis for Tb-mesoMOF: C, 41.59%; H, 3.35%;
N, 5.92%; MP-11@TbmesoMOF:C, 42.87%; H,4.88%; N, 8.09%) was monitored by the disappearance
of the Soret band at 400 nm in the supernatant (Figure 2.5a),35 and a loading of 19.1 μmol/g was reached
after ∼50 h. For MCM-41(Figure 2.5b), the same procedures and conditions were followed using MP-11
and incubation time of 97 hours to achieve saturation. As displayed in Figure 2.6c, the color of TbmesoMOF crystals turns dark red after being saturated with MP-11. Single crystal opticalabsorption
spectroscopy studies revealed that the spectrum of MP-11@Tb-mesoMOF exhibits a Soret band at ∼410
nm, while the corresponding Soret band of MP-11 in buffer solution is 400 nm (Figure 2.6d); the
bathochromic shift of the encapsulated MP-11 in the Tb-mesoMOF is indicative of the interactions
between the trapped MP-11 molecules and the hydrophobic nanoscopic cages.39 N2 sorption isotherms
(Figure 2.6a) measured at 77 K indicated that the BET surface area of Tb-mesoMOF decreases from 1935
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m2/g (Langmuir surface 3247 m2/g) to 400 m2/g (Langmuir surface 615 m2/g) after saturation with MP-11,
indicating a majority of the free space in Tb-mesoMOFis occupied by MP-11 molecules. Pore size
distribution analysis revealed that the pore size of MP-11@Tb-mesoMOF is predominately around 0.9 nm,
while the pores of 4.1 and 3.0 nm observed in Tb-mesoMOF disappeared (Figure 2.6b). We inferred from
these observations that MP-11 molecules should reside in the nanoscopic cages after saturation, while the
remaining micropores of 0.9 nm can provide a mechanism for substrates to access the active MP-11
centers housed therein.

(a)

(b)
Figure 2.5 (a)UV-Vis spectra of MP-11 in the supernatant of MP-11 HEPES buffer immersed with Tb-mesoMOF; (b) UV-Vis
spectra of MP-11 in the supernatant of MP-11 HEPES buffer immersed with MCM-41.
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Figure 2.6 (a) N2 sorption isotherms, and (b) pore size distributions of Tb-mesoMOF and MP-11@Tb-mesoMOF; (c) optical
images of Tb-mesoMOF and MP-11@Tb-mesoMOF; (d) normalized single-crystal absorbance spectrum derived from specular
reflectance for MP-11@ Tb-mesoMOF (red) and solution optical spectrum for free MP-11 in buffer solution (black).

MP-11 is well-known to conduct peroxidation of organic molecules by the use of hydrogen peroxide.34
Unfortunately, free MP-11 tends to aggregate in solution, which leads to lessaccessibility for the heme,
thus, adversely affecting its activity.40 Immobilization in a suitable host material prevents aggregation,
renders the heme more accessible to substrates,41 and allows a broad range of solution conditions.
Mesoporous silica materials have been widely investigated for enzyme immobilization,20,21 and we
selected MCM-41 for comparison. MCM-41 adsorbs MP-11 (hereafter denoted MP-11@MCM-41) with a
lower loading capacity of 3.4 μmol/g presumably due to its lower surface area (BET surface area: ∼1000
m2/g) compared to Tb-mesoMOF. Catalytic experiments were performed for MP-11@Tb-mesoMOF,
MP-11@MCM-41, free MP-11, and Tb-mesoMOF.
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Figure 2.7 Reaction Scheme for Oxidation of 3,5-Di-t-butylcatechol to o-Quinone.

As polyphenols are routinely used to evaluate the peroxidase activity of porphyrin catalysts,36 the
catalytic activities of MP-11@Tb-mesoMOF and MP-11@MCM-41 were assessed by monitoring the
oxidation of the chromogenic substrate 3,5-dit-butyl-catechol (DTBC) at 420 nm for the formation of the
corresponding o-quinone product (Figure 2.7).36 The reactions for MP-11@Tb-mesoMOF, MP11@MCM-41, and Tb-meso-MOF were performed at room temperature in methanol solution with H2O2
added, while the catalytic activity of free MP-11 was investigated in HEPES buffer due to its insolubility
and complete inactivity in methanol.

Figure 2.8 Kinetic traces for the oxidation of DTBC by (a) free MP-11in HEPES buffer (0.6 μM); (b) MP-11@Tb-mesoMOF
(2.0 mg), Tb-mesoMOF(2.0 mg), and MP-11@MCM-41 (2.0 mg) in methanol with H2O2.
Table 2.1 Summary of Catalysis Results of Oxidizing DTBC to o-Quinone in the Presence of 10 mM H2O2 in Methanol
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Free MP-11 in HEPES buffer solution demonstrates a fast initial rate of 8.93×10-4 mM/s (Figure 2.8a;
Table 2.1) as derived from the slope in the first 2 min. However, it starts to lose activity after only 3 min
due to the aggregation in solution.40 Without MP-11, the reaction for Tb-mesoMOFis going very slowly
with a rate of only 2.62×10-6 mM/s; in comparison, MP-11@MCM-41 reacts more than 10 times faster
with a rate of 3.57×10-5 mM/s (without MP-11, MCM-41 also demonstrates a very slow reaction rate as
shown Figure 2.9). An even higher rate of 7.58×10-5 mM/s is observed for MP-11@Tb-mesoMOF during
the initial time period of ∼30min (Figure 2.8b, Table 2.1). After 25 h (Table 2.1), no more o-quinone was
generated, and a low final conversion of 12.3% was found for free MP-11 in buffersolution, which can be
ascribed to the fast deactivation of MP-11 as a result of aggregation in solution. A final conversion of
12.2% was observed for Tb-mesoMOF in methanol solution, meaning Tb-mesoMOF exhibits low activity
for the oxidation of DTBC to o-quinone. MP-11@MCM-41 demonstrated an enhanced activity with a
final conversion of 17.0%, but the catalyst was bleached out owing to the leaching of MP-11 during the
assay (Figure 2.10). In contrast, the color of MP-11@Tb-mesoMOF remained dark red with no MP-11
found in the supernatant after the reaction, and a much higher conversion of 48.7% was obtained (Table
2.1). These experiments indicated that the microperoxidase catalyst was greatly stabilized through the
mesoporous MOF host matrix.

Figure 2.9 Kinetic trace for the reaction of MCM-41, which reveals a rate of 5.20 × 10-5 mM/sec (the final conversion is 6.0%
after 25 hours).
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Figure 2.10 UV-Vis spectrum of the supernatant for MP-11@MCM-41 assay indicating severe leaching of MP-11.

The recyclability of MP-11@Tb-mesoMOF was also evaluated by checking its catalytic activities at
different cycles. As shown in Figure 2.11, the reaction rate of MP-11@Tb-mesoMOF fluctuates from
5.40×10-5 to 8.34×10-5 mM/s in the first six cycles; it decreases to 3.56×10-5 mM/s at the seventh cycle,
representing ∼53% activity drop compared to that of the first cycle (Table 2.2). In comparison, the
activity of MP-11@MCM-41 decreases abruptly with more than 60% activity lost after the first cycle, and
only 28% activity remains at the third cycle (Table 2.2). The fast decay of MP-11@MCM-41 originates
from the leaching of MP-11, which was detected in the supernatant (Figure 2.10). No MP-11 leaching
was observed for MP-11@Tb-mesoMOF over seven cycles, and the Tb-mesoMOF host could still
maintain its framework intregrity after catalytic cycles as evidenced by the powder X-ray diffraction
studies (Figure 2.12). I reasoned that the capability of MP-11@Tb-mesoMOF to retain activity for at least
six cycles could be attributed to the strong hydrophobic interactions between the Tb-mesoMOF
framework and MP-11 molecules trapped in the hydrophobic nanoscopic cages, preventing their escape
from the MOF host matrix.
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Table 2.2 Summary of reaction rates at different catalytic cycles.

Figure 2.11 Reaction rates of MP-11@Tb-mesoMOF and MP-11 @MCM-41 at different cycles.

Figure 2.12 PXRD patterns for Tb-mesoMOF, MP-11@Tb-mesoMOF, and MP-11@TbmesoMOF after catalytic cycles.
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2.2.4 Conclusion
In summary, here I have demonstrated for the first time the successful immobilization of
microperoxidase-11 into a mesoporous MOF consisting of nanoscopic cages, which exhibited superior
enzymatic catalysis performances compared to mesoporous silica material MCM-41. The high catalytic
activity together with recyclability and solvent adaptability for MP-11encapsulated in the Tb-mesoMOF
with a well-defined structure promises that mesoporous MOFs might serve as a new type of host matrix
material to immobilize enzymes for catalysis applications in organic solvents. Considering the richness of
mesoporous MOF structures, the present studies also open a new avenue for enzyme immobilization as
heterogeneous biocatalysts.

2.3 Size-Selective Biocatalysis of Myoglobin Immobilized into a Mesoporous
Metal-Organic Framework with Hierarchical Pore Sizes
2.3.1 Introduction
Biocatalysis has long been of great interest in both academia and industry.19 However, the successful
utilization of proteins as biocatalysts in chemical, pharmaceutical, and food industries largely relies on the
ability to successfully stabilize them in what is often an unnatural environment while retaining their
functions and activities.21b Immobilization of the biocatalysts on solid supports presents the advantages of
enhanced stability as well as ease of separation and facile recovery for reuse. 20,21a In addition, if a solid
support possesses a hierarchy of pore sizes with large pores for protein ingress and small pores to allow
diffusion of reactants and products, the size-, or shape-selective catalysis which is highly desirable in
industry but usually cannot be exhibited by native proteins,21a could be expected. Over the past two
decades, extensive efforts have been dedicated to the search for various types of host matrix materials,
and current attention has been focused on mesoporous silica materials owing to their high surface areas as
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well as tunable and uniform pores.20,21 Nevertheless, due to the lack of specific interactions with protein
molecules, mesoporous silica materials suffer from leaching during the reaction process, which in return
results in loss of activity upon reuse; additionally, no size- and shape-selective catalysis has ever been
observed presumably owing to the difficulty to achieve hierarchical pores for mesoporous silica
materials.20,21 These have been recognized as some major hurdles limiting their applications in
biocatalysis, thus prompting the search for new types of host matrix materials.21
One of the promising host matrix candidates is mesoporous metal-organic framework (MOF) material,
which has been advanced in recent years.22,32 Compared with mesoporous silica materials, mesoporous
MOFs possess higher surface areas and pore walls composed of functional organic groups which could
afford specific interactions with protein molecules thus avoiding leaching. In addition, mesoporous MOFs
can be tailored to possess hierarchical pores with mesopores to accommodate biomolecules and
micropores to selectively allow diffusion of reactants and products thus possibly resulting in size-, or
shape-selective catalysis.
As mentioned above, the successful immobilization of the “micro-enzyme” MP-11 into a mesoporous
MOF was demonstrated for the first time, which exhibited superior enzymatic catalysis performance
compared to mesoporous silica material.42 Although the small MP-11 is not a real protein molecule
despite its enzymatic peroxidation function,34 this work paved the first step to develop mesoporous MOFs
as a new type of host matrix materials for biocatalysis application and also encouraged me to explore the
possibility to immobilize protein molecules into mesoporous MOFs. Herein, myoglobin (Mb) was
selected to be immobilized into MOF. Mb is a small oxygen binding protein of muscle cells with a
molecular dimension of about 2.1 × 3.5 × 4.4 nm.43 It contains a single polypeptide chain of 153 amino
acid residues and a heme prosthetic group in a hydrophobic pocket (Figure 2.13a).44 The biocatalytic
performances of Mb are usually evaluated through its peroxidative activity which originates from the
heme prosthetic group.45 Considering its stability in buffer solutions, I continue to employ the recently
reported mesoporous MOF, Tb-mesoMOF as host matrix for the “proof of concept” studies on
immobilizing Mb protein molecules. Crystallographically, Tb-mesoMOF consists of nanoscopic cages of
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3.9 and 4.7 nm in diameter (Figure 13b,c),2 and features type-IV sorption behavior with hierarchical pore
sizes of 0.9 nm, 3.0 nm and 4.1 nm as revealed by N2 gas sorption studies at 77 K.42 Since Mb molecule
possesses highly dynamic and flexible structure, it is expected to squeeze into Tb-mesoMOF through the
mesopores via a specific orientation, and the 4.7 nm-diameter cages may serve as the ideal room to
accommodate the Mb molecules.
Indeed, Mb can be immobilized into the mesoporous MOF in spite of its apparent larger molecular size
than the pore sizes of Tb-mesoMOF. The resulting Mb@Tb-mesoMOF not only exhibited superior
biocatalytic performances compared to the mesoporous silica counterpart, but also demonstrated
interesting size-selective biocatalysis due to the hierarchical pore sizes of the Tb-mesoMOF.

Figure 2.13 (a) Molecular structure of myoglobin (PDB 3LR7, ferric horse heart myoglobin); (b) 3.9 nm-diameter cage, and (c)
4.7 nm-diameter cage in Tb-mesoMOF.

2.3.2 Experimental Section
(i)Materials Syntheses
Crystalline samples of the mesoporous MOF, Tb-mesoMOF and the mesoporous silica material, SBA15 were prepared according to the procedures reported in ref. 2 and ref. 46 respectively. Tb(NO3)3⋅5H2O
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(0.030 g, 6.90 x 10-5 mol) and 4,4’,4”-s-trizaine-2,4,6-triyltribenzoic acid, H3TATB (0.010 g, 2.27 x 10-5
mol) was dissolved in a DMA/MeOH/H2O (2.0 / 0.4 / 0.1 mL) in a 20 mL vial at ambient temperature.
The reaction mixture in a capped vial was heated in an oven at 105 ºC for 2 days. Colorless truncated
octahedral crystals were obtained with the yield of 44.6 % based on the 1.0 mol of H3TATB.
(ii)Myoglobin uptake experiments
Typically 2.5 mg/mL of met-myoglobin from equine skeletal muscle (SigmaAldrich) was prepared in
2.0 mL 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer added into 5.0 mg of TbmesoMOF and incubated at 37°C for 94 hours. The protein concentration in the supernatant was
determined at different time points using the BCA method of protein determination (Bicinchoninic Acid
protein assay using bovine serum albumin as the standard) in order to establish the uptake of Mb. 47 For
the SBA-15 (5.0 mg) the same procedure and conditions were followed. For each preparation, a sample of
the Mb solution was also incubated under the same conditions and was used to determine the reference
concentrations.
(iii)Examination of the catalytic activities
The initial rates for ABTS+• formation were monitored using 0.5 mM 2,2′ azinodi(3ethylbenzthiazoline)-6-sulfonate (ABTS) in presence of 10 mM H2O2 in HEPES buffer by various
catalysts discussed in this work (~5mg used for each solid catalyst and 0.5µM in HEPES buffer for free
Mb) on a Varian CARY50 spectrophotometer. The oxidation of the substrate to the corresponding
oxidized product ABTS+• was directly monitored at 660 nm (ε = 12 M-1cm-1)48 by taking the absorption
spectra of the supernatant solution at various time points over the reaction.
The initial rates of trihydroxybenzene (THB) oxidation were monitored using 0.5 mM THB in
presence of 10 mM H2O2 in HEPES buffer by various catalysts discussed in this work (~5mg used for
each solid catalyst and 0.5 µM in HEPES buffer for free Mb) also on a Varian CARY50
spectrophotometer. The oxidation of the substrate to the corresponding oxidized product purpurogallin
dimer were directly monitored at 420 nm (ε = 2640 M-1cm-1)49 by taking the absorption spectra of the
supernatant solution at various time points over the reaction.
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(iv) N2 sorption measurements
N2 sorption isotherms of Tb-mesoMOF and Mb@Tb-mesMOF were collected using the surface area
analyzer ASAP-2020. Before the measurements, the freshly prepared samples were thoroughly solventexchanged with methanol, and activated under dynamic vacuum first at room temperature overnight and
then at 120 °C for two hours. The surface area of Tb-mesoMOF is comparable with that reported in ref. 2
for the sample activated at 80 °C.

2.3.3 Result and Discussion
To explore the possibility to immobilize the large Mb protein molecule, freshly prepared Tb-mesoMOF
crystals were immersed in Mb solution of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)
buffer, and placed in an incubator at 37 °C. The uptake of Mb by Tb-mesoMOF at different time points
was determined by using the BCA method for protein determination,47 and a saturated loading of 9.1
µmol/g was reached after ~94 hours (Figure 2.14). The Mb saturated Tb-mesoMOF sample (hereafter
denoted Mb@Tb-mesoMOF) was then washed with fresh buffer solution several times until the
supernatant became colorless to fully remove loosely attached Mb molecules on the surface. The
successful immobilization of large Mb protein molecules into Tb-mesoMOF was confirmed by optical
image and UV-Vis spectroscopy studies. As displayed in Figure 2.15a, the color of Tb-mesoMOF crystal
turns dark brown after being saturated with Mb, which strongly indicates the ingress of Mb molecules
into Tb-mesoMOF. Solid-state UV-Vis absorption spectroscopy studies revealed that Mb@Tb-mesoMOF
exhibited a Soret band at ~412 nm, which represents a slight bathochromic shift compared to the Soret
band of ~410 nm for Mb in buffer solution (Figure 2.15b), indicating the interactions between the trapped
Mb molecules and the framework of Tb-mesoMOF.50 N2 sorption isotherms (Figure 2.15c) measured at
77 K indicated that the BET surface area of Tb-mesoMOF decreases from 1935 m2/g (Langmuir surface
3247 m2/g) to 462 m2/g (Langmuir surface 642 m2/g) after saturation with Mb. Pore size distribution
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analysis revealed that the pore size of Mb@Tb-mesoMOF is predominately around 0.8 nm while the
pores of 4.1 nm and 3.0 nm observed in Tb-mesoMOF disappeared (Figure 2.15d). We deduced from
these observations that Mb molecules block the two types of mesopores, while the remaining micropores
of ~0.8 nm can provide a pathway for small substrates to access the active Mb centers housed in the 4.7
nm-diameter cages. The results from gas sorption studies also support the successful immobilzation of
Mb into Tb-mesoMOF.
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Figure 2.14 Uptake of myoglobin for Tb-mesoMOF and SBA-15 in HEPES buffer.

Mb is known to perform peroxidation of organic substrates by the use of hydrogen peroxide, 45 and its
peroxidase activity is usually assessed with the assay of 2,2′ azinodi(3-ethylbenzthiazoline)-6-sulfonate
(ABTS) as a redox indicator by monitoring the rate of increase in absorbance at 660 nm (ε = 12 mM-1 cm1

for ABTS+•) subsequent to the addition of peroxide (Figure 2.15).48 Since mesoporous silica materials

have been widely investigated for protein immobilization,20,21 we selected SBA-1551 for comparison.
SBA-15 with the pore size mono-distributed around 8.5 nm adsorbs Mb (hereafter denoted Mb@SBA-15)
with a lower loading capacity of 7.0 µmol/g (Figure 2.14) presumably due to its lower surface area (BET
surface area: ~900 m2/g, Figure 2.17) compared to Tb-mesoMOF. Assays of ABTS oxidation were
conducted for Mb@Tb-mesoMOF, Mb@SBA-15, and free Mb at room temperature in HEPES buffer.
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Figure 2.15 (a) Optical images of Tb-mesoMOF and Mb@Tb-mesoMOF; (b) UV-Vis absorption spectra for Mb@Tb-mesoMOF
(black) and free Mb in buffer solution (red); (c) N2 sorption isotherms, and (d) Pore size distributions of Tb-mesoMOF and
Mb@Tb-mesoMOF.

Figure 2.16 Reaction scheme for oxidation of ABTS by hydrogen peroxide catalyzed by Mb.

Figure 2.17 (a) N2 sorption isotherms of SBA-15 at 77 K, which reveals a BET surface area of ~900 m2/g; (b) pore size
distribution of SBA-15.

45

As shown in Figure 2.18, free Mb in solution demonstrates a very fast initial rate of 3.27 × 10-4 mM/sec
for ABTS+• formation as expected; and a high initial rate of 2.00 × 10-4 mM/sec is observed for
Mb@SBA-15 (Table 2.3), which is consistent with the values reported in the literatures.52 However, an
extremely low initial rate of 8.33 × 10-6 mM/sec is found for Mb@Tb-mesoMOF, which is almost
inactive for ABTS+• formation despite a larger amount of Mb trapped in Tb-mesoMOF compared to SBA15. We reasoned that the very low initial rate of Mb@Tb-mesoMOF for ABTS+• formation should be
attributed to its small available pore size of ~0.8 nm, which does not allow the large ABTS substrate with
a molecular dimension 10.1 Å × 17.3 Å to access the active Mb centers housed in Tb-mesoMOF. This
prompts us to evaluate its possible size-selective biocatalysis performance by assaying a smaller substrate.

Figure 2.18 Kinetic traces for the oxidation of ABTS (a), and THB (b), by Free Mb, Mb@Tb-mesoMOF, and Mb@SBA-15 with
H2O2 in HEPES buffer.

Table 2.3 Summary of catalysis results of oxidizing ABTS and THB in the presence of 10 mM H2O2 in HEPES buffer.

Initial rate for ABTS+•
formation (mM/sec)[b]
Initial rate for THB
oxidation[c] (mM/sec)
Average Rate for THB
oxidation [d] (mM/sec)

Free Mb[a]

Mb@SBA-15

3.27× 10-4

2.00 × 10-4

Mb@TbmesoMOF
8.33× 10-6

1.02 × 10-5

8.96 × 10-5

4.80 × 10-5

8.20 × 10-6

6.10 × 10-6

1.55 × 10-5

[a] Diluted to 0.5 M in HEPES buffer; [b] initial rate calculated in the first four minutes; [c] initial rate calculated in the first
five minutes; [d] average rate over one hour.
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Polyphenols are also routinely used to evaluate the peroxidase activity of Mb, although its activity is
about one fourth of the ABTS system.36 To evaluate the biocatalytic activity as well as to confirm the
possible size-selective biocatalysis performance of Mb@Tb-mesoMOF, we selected the small polyphenol
1,2,3-trihydroxybenzene (THB) (or pyrogallol) which has a molecular dimension of 5.7 Å × 5.8 Å as the
substrate by monitoring its oxidation at 420 nm for the formation of the corresponding purpurogallin
dimer product (molecular dimension: 5.8 Å × 7.5 Å) (Figure 2.19).49Given the small substrate molecule
can access the active Mb centers through the 0.8 nm pore which can also facilitate the exit of the product
molecule, we expected Mb@Tb-mesoMOF should exhibit a much higher activity of oxidizing THB
compared to ABTS.
OH
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Figure 2.19 Reaction scheme for oxidation of THB by hydrogen peroxide catalyzed by Mb.

As expected, Mb@Tb-mesoMOF demonstrates a high initial rate of 4.80 × 10-5 mM/sec using THB as
substrate (Figure 2.18, Table 2.3), which is about half of free Mb with a rate of 1.02 × 10-4 mM/sec. The
slower initial rate for Mb@Tb-mesoMOF compared to free Mb should originate from the slow diffusion
of the substrates from solution into Mb@Tb-mesoMOF through the micropores of 0.8 nm. Whereas the
observed high rate of 8.96 × 10-5 mM/sec for Mb@SBA-15 can be attributed to the severe leaching of Mb
(Figure 2.20), which actually was also responsible for the high initial rate for ABTS+• formation in
Mb@SBA-15. Nevertheless, after one hour, Mb@Tb-mesoMOF exhibits a much faster average rate of
1.55 × 10-5 mM/sec compared to Mb@SBA-15 (rate: 6.10 × 10-6 mM/sec) and free Mb (rate: 8.20 × 10-6
mM/sec). The significant lower average rates for Mb@SBA-15 and free Mb can be attributed to internal
decomposition of the protein active site in solution,53 which inversely indicates the enhanced stability of
Mb enforced by the Tb-mesoMOF framework. The above results of kinectic studies also indicate that
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Mb@Tb-mesoMOF indeed demonstrates selective biocatalysis of oxidizing small THB over large ABTS
due to the size effect.
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Figure 2.20 UV-Vis spectrum of the superanant for Mb@SBA-15 assay, revealing a leaching of free Mb in HEPES buffer.

One of the important issues for biocatalysis is the reusability of the catalysts. To evaluate the
recyclability of Mb@Tb-mesoMOF, we checked its catalytic activities at different cycles. As shown in
Figure 2.21a, the reaction rates of THB oxidation for Mb@Tb-mesoMOF fluctuate from 3.84 × 10-5
mM/sec to 4.80 × 10-5 mM/sec over fifteen cycles; it slightly decreases to 3.20 × 10-5 mM/sec at the
sixteenth cycle, representing ~33% activity drop compared to that of the first cycle (Table 2.4). In
comparsion, the activity of Mb@SBA-15 decreases abruptly with more than 40% activity loss after the
first cycle, and less than 18% activity remains at the third cycle (Figure 2.14, Table 2.4). The fast decay of
Mb@SBA-15 can be ascribed to the severe leaching of Mb, which was detected in the supernatant
(Figure 2.20). No Mb leaching was observed for Mb@Tb-mesoMOF over the sixteen cycles of reactions.
We reasoned that the capability of Mb@Tb-mesoMOF to retain activity for at least fifteen cycles could be
attributed to the strong interactions between the Tb-mesoMOF framework and the Mb molecules trapped
in the 4.7 nm-diameter cages, which prevent their escape from the MOF host matrix. This also suggests
that the Mb molecules can be greatly stabilized via the mesoporous MOF host matrix. In addition, the
relationship between the Mb loading amount and the catalytic performance was also investigated. As
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shown in Figure 2.21b, the profile of Mb uptake and the change of catalytic reaction rates was consistent
to each other, which means to a certain degree, the more protein that was loaded, the higher catalytic
capacity the biocatalyst could exhibit.
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Figure 2.21 (a) Reaction rates of THB oxidation for Mb@Tb-mesoMOFand Mb@SBA-15 at different cycles. (b) (exterior) the
upload profile of Mb into Tb-mesoMOF. (interior) The reaction rates catalyzed by Mb@Tb-mesoMOF with different Mb loading
amount.

Table 2.4 Summary of reaction rates at different catalytic cycles.

Cycle
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

Mb@TbmesoMOF
(mM/sec)
4.80× 10-5
3.84× 10-5
4.16× 10-5
4.48× 10-5
4.16× 10-5
3.84× 10-5
4.80× 10-5
4.80× 10-5
3.84× 10-5
4.16× 10-5
4.48× 10-5
4.16× 10-5
3.84× 10-5
4.16× 10-5
4.16× 10-5

16

3.20× 10-5
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Mb@ SBA-15
(mM/sec)
8.96× 10-5
5.12× 10-5
1.60× 10-5

2.3.4 Conclusion
In summary, here I have demonstrated for the first time the successful immobilization of the protein
myoglobin into a mesoporous MOF with hiearchical pore sizes, which exhibited unprecedented sizeselective biocatalysis as well as superior catalytic activities toward small substate oxidation compared to
mesoporous silica material SBA-15. The interesting size-selective biocatalysis together with enhanced
stability and excellent recyclability for Mb encapsulated in the Tb-mesoMOF not only promises that
mesoporous MOFs could serve as a new type of host matrix materials to immobilize proteins for industryrelated biocatalysis applications, but also makes mesoporous MOFs stand out of traditional host matrix
materials for proteins immobilization particularly when considering their structural versatility and design
amenability.

2.4 Biocatalysis and Kinetic studies of Cyt c@Tb-mesoMOF in Organic
Slovents

2.4.1 Introduction
Due to the high efficiency, high stereo-, chemo-, and regioselectivity of enzymes,19 biocatalysis has
long attracted great and broad interest in many fields, such as chemical pharmaceutical, food and energy
production. The development of materials and effective methods for enzyme immobilization is essential
for further industrial application of biocatalysis. In particular, because of the fragile and sensitive nature
of proteins, how to successfully stabilize enzymes/proteins in what is often an unnatural environment
while retaining their functions and activities is quite challenge. Immobilization of the biocatalysts on solid
supports possesses the advantages of enhanced stability as well as ease separation and facile recovery for
reuse.20,21 Mesoporous silica is one of the most widely investigated materials for biocatalysis application.
However, the leaching of the immobilized enzyme during the reaction process remains an issue for the
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further development of this material in biocatalysis. Post-synthetic modification of pore walls with
functional organic groups has been widely pursued as a strategy to prevent leaching, but this inevitably
leads to significant decrease of enzyme loading and/or blockage of the channels. Therefore, in this project,
I encapsulated cytochrome c into Tb-mesoMOF and systematically investigated the biocatalysis and
kinetics of the afforded Cyt c@Tb-mesoMOF in organic solvents (Figure 2.22). The catalytic
performance of Cyt c@mesoMOF was compared with its mesoporous silica counterpart Cyt c@MCM-41
and free cytochrome c to illustrate if mesoMOF matrix can stabilize the enzyme, and protect it from
inactivation upon encapsulation.

Figure 2.22 Encapsulation of Cytochrome c into Tb-mesoMOF.

Cytochrome c (Cyt c) is a relatively small structurally robust heme protein with a molecular dimension
of ~ 2.6 × 3.2 × 3.3 nm, and serves as a component of the electron transport chain in mitochondria as well
as being involved as a signal associated withapoptosis.54 The protein consists of a single polypeptide
chain of 104 amino acid residues containing a covalently attached heme group. (Figure 2.3c).55

2.4.2 Experimental Section
(i)Materials Syntheses and preparation
Crystalline samples of the mesoporous MOF, Tb-mesoMOF was prepared according to the procedures:
Tb(NO3)3⋅5H2O (0.030 g, 6.90 x 10-5 mol) and 4,4’,4”-s-trizaine-2,4,6-triyltribenzoic acid, H3TATB
(0.010 g, 2.27 x 10-5 mol) was dissolved in a DMA/MeOH/H2O (2.0 / 0.4 / 0.1 mL) in a 20 mL vial at
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ambient temperature. The reaction mixture in a capped vial was heated in an oven at 105 ºC for 2 days.
Colorless truncated octahedral crystals were obtained with the yield of 44.6 % based on the 1.0 mol of
H3TATB. The mesoporous silica MCM-41 and enzyme cytochrome c (from equine heart) was purchased
from SigmaAldrich.
(ii)Cytochrome c uptake experiments
Typically 2.5 mg/mL of cytochrome c from equine skeletal muscle was prepared in 2.0 mL 4-(2hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer added into 5.0 mg Tb-mesoMOF, and
incubated at 37°C for 72 hours. The protein concentration in the supernatant was determined at different
time points using the BCA method of protein determination (Bicinchoninic Acid protein assay using
bovine serum albumin as the standard) in order to establish the uptake of Cyt c. For the MCM-41(5.0 mg)
the same procedure and conditions were followed. For each preparation, a sample of the Cyt c solution
was also incubated under the same conditions and was used to determine the reference concentrations.
(iii) Examination of the catalytic activities
The initial rates for ABTS+• formation were monitored using 0.5 mM 2,2′ azinodi(3ethylbenzthiazoline)-6-sulfonate (ABTS) in presence of 10 mM H2O2 by various catalysts discussed in
this work (~5mg used for each solid catalyst and 0.5M in HEPES buffer, methanol or ethanol) on a
JASCO V670 spectrophotometer. The oxidation of the substrate to the corresponding oxidized product
ABTS+• was directly monitored at 660 nm (ε = 12 M-1cm-1)48 by taking the absorption spectra of the
supernatant solution at various time points over the reaction.
The initial rates of oxidation of DTBC by various catalysts discussed in this work in the presence of 10
mM H2O2 in different solution (methanol or enthanol) were determined on a JASCO V670
spectrophotometer. The oxidation of the substrate to the corresponding o-quinone dimer product was
directly monitored at 420 nm (ε=1,910 M-1cm-1) by taking the absorption spectra of the supernatant
solution at various time points in the reaction.36
The initial rates of trihydroxybenzene (THB) oxidation were monitored using 0.5 mM THB in presence
of 10 mM H2O2 in different solution (HEPES buffer, methanol or enthanol) by various catalysts discussed
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in this work (~5mg used for each solid catalyst and 0.5 M in HEPES buffer, methanol or ethanol) also
on a JASCO V670 spectrophotometer. The oxidation of the substrate to the corresponding oxidized
product purpurogallin dimer were directly monitored at 420 nm (ε = 2640 M-1cm-1)49 by taking the
absorption spectra of the supernatant solution at various time points over the reaction.
(iv) N2 sorption measurements
N2 sorption isotherms were collected using the surface area analyzer ASAP-2020. Before the
measurements, the freshly prepared samples were thoroughly solvent-exchanged with methanol, and
activated under dynamic vacuum first at room temperature overnight and then at 120 oC for two hours.
The surface area of Tb-mesoMOF is comparable with that reported in ref. 2 for the sample activated at 80
o

C.

2.4.3 Result and Discussion

The uptake of cytochrome c by Tb-mesoMOF at different time points was determined by using the
BCA method for protein determination, as well as monitored by UV-vis (Figure 2.23b). A saturated
loading of 10.8 µmol/g was reached after ~72 hours (Figure 2.23a). This loading amount is lower than the
uptake of MP-11 (19.1 µmol/g), and higher than the uptake of myoglobin (9.1 µmol/g) in the same TbmesoMOF system, which is probably due to the dimensions of cytochrome c is significantly lartger than
MP-11 and slightly smaller than myoglobin. The cytochrome c saturated Tb-mesoMOF sample (hereafter
denoted Cyt c@Tb-mesoMOF) was then washed with fresh buffer solution several times until the
supernatant became colorless to fully remove loosely attached Cyt c molecules on the surface. The
successful immobilization of cytochrome c molecules into Tb-mesoMOF was confirmed by optical image
(Figure 2.23c) and solid state UV-Vis spectroscopy (Figure 2.23d).
As displayed in Figure 2.23c, the color of Tb-mesoMOF crystal turns dark red after being saturated
with Cyt c, which strongly indicates the ingress of Cyt c molecules into Tb-mesoMOF. Solid-state UV-
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Vis absorption spectroscopy studies revealed that Cyt c@Tb-mesoMOF exhibited a Soret band at ~412
nm, which represents a slight bathochromic shift compared to the Soret band of ~409 nm for Cyt c in
buffer solution (Figure 2.23d), indicating the interactions between the trapped Cyt c molecules and the
framework of Tb-mesoMOF. The results from gas sorption studies also support the successful
immobilzation of Cyt c into Tb-mesoMOF. N2 sorption isotherms (Figure 2.23e) measured at 77 K
indicated that the BET surface area of Tb-mesoMOF decreases from 1935 m2/g (Langmuir surface 3247
m2/g) to 404 m2/g (Langmuir surface 563 m2/g) after saturation with Cyt c. As one of the typical
hemoproteins, cytochrome c is known to catalyze oxidation of various organic substrates in the present of
H2O2. The peroxidative activity in various solutions is evaluated here by three reactions: (1) the assay of
2,2'-azinodi(3-ethylbenzthiazoline)-6-sulfonate (ABTS) as a redox indicator by monitoring the rate of
increase in absorbance at 660 nm (ε = 12 mM-1 cm-1 for ABTS (Figure 2.24a)48; (2) the assay of 1,2,3trihydroxybenzene (THB) (or pyrogallol) as the substrate by monitoring its oxidation at 420 nm for the
formation of the corresponding purpurogallin dimer product(Figure 2.24b);49 (3) the oxidation of the
chromogenic substrate 3,5-dit-butyl-catechol (DTBC) at 420 nm for the formation of the corresponding oquinone product (Figure 2.24c).36 The first assay (oxidation of ABTS) involves electron transfer, whereas
the second assay (the oxidation of THB) necessitates oxygen transfer. These reactions are routinely used
to evaluate the peroxidase activity of porphyrin catalysts. Control experiments were carried out using free
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Figure 2.23 (a) Supernatant decrease of Cyt c over time for Tb-mesoMOF. (b) UV-vis spectrum of Cyt c in the supernatant upon
incubation with Tb-mesoMOF at different timeframe. (c) Optical images of Tb-mesoMOF(up) and Cyt c@Tb-mesoMOF (down).
(d) UV-Vis absorption spectra for Cyt c@Tb-mesoMOF (black) and free Cyt c in HEPES buffer solution (red). (e) N2 sorption
isotherms of Tb-mesoMOF and Cyt c@Tb-mesoMOF.
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Figure 2.24 Reaction scheme for oxidation of (a) ABTS (b) THB and (c) DTBC by hydrogen peroxide catalyzed by Cyt c.

Kinetic studies revealed that Cyt c@Tb-mesoMOF exhibited excellent peroxidase-like catalytic activity
in organic solvents and in buffer (pH 7.5 HEPES buffer and pH 6 MES buffer). The catalytic activities of
the samples were investigated by enzyme kinetics theory (michaelis menten equation) and methods using
the above three reactions (Figure 2.25). The catalytic activity of Cyt c@Tb-mesoMOF in the oxidation of
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ABTS was investigated under the optimum conditions in pH 6 MES (2-(N-morpholino) ethanesulfonic
acid) buffer. The turn over number (maximum number of substrate molecules turned over per catalyst
molecule per unit time, kcat), the Michaelis−Menten constant (associated with the affinity of the catalyst
molecules for the substrate, Km), and the catalytic efficiency (kcat/Km) were obtained using a
Michaelis−Menten curve fit (Table 2.5a). Generally, the evaluation of a biocatalyst cannot be arbitrarily
determined by the turn over number (Vmax or kcat), but has to take the affinity of the catalyst molecules to
the substrate into consideration. Therefore, the biocatalyst should be comprehensively evaluated by
kcat/Km values.
In the oxidation reaction of ABTS, the Michaelis-Menten constant (Km) revealed a significant higher
affinity of the homogeneous Cyt c (0.062 mM) towards the ABTS substrate in MES buffer compared to
Cyt c@Tb-mesoMOF (0.393 mM). This is because the heterogeneous catalytic system of Cyt c@TbmesoMOF requires substantial mass transfer of the relative large substrate (ABTS molecular dimension
10.1 Å × 17.3 Å) over the heterogeneous phase, which decreased the affinity of catalytic active center
towards substrate in the solution. The drived kcat of Cyt c@Tb-mesoMOF is 0.695 min-1, which is
comparable to the free kcat of free Cyt c in pH 6 MES buffer (0.630 min-1). Overall, Cyt c@TbmesoMOF exhibits relative low catalytic efficiency (kcat/Km=1.703) in comparison with free Cyt c in
buffer (kcat/Km=10.12) due to the duffusion of larte substrate ABTS in heterogenous system.
The catalysis of oxidation reaction of THB was evaluated in pH 7.5 HEPES buffer, methanol and
ethanol under room Temprature (Table 2.5b), and some interesting kinetic results were obtained. Firstly,
in pH 7.5 HEPES buffer, Cyt c@Tb-mesoMOF demonstrated similar (free Cyt c:Km=0.484mM; Cyt
c@Tb-mesoMOF: Km=0.476mM) affinity towards small organic substrate THB (molecular dimentions:
5.8 Å × 7.5 Å), which means the mass transfer of small THB molecule over the heterogenous phase was
relative easy, and have no significant influence on the affinity of Cyt c@Tb-mesoMOF towards THB
substrate. This oberservation is consistent with the results from Mb@Tb-mesoMOF system,56 and further
confirmed the conclusion of size selective biocatalysis upon encapsulation of protein into Tb-mesoMOF.
Overall, the catalytic efficiency of Cyt c@Tb-mesoMOF (kcat/Km=10.126) approaches that of free
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cytochrome c (kcat/Km=17.153) in buffer system. More interestingly, the Michaelis-Menten constant (Km)
revealed a dramatic decrease in affinity of free Cyt c towards subsrate in methanol (Km=1.86 mM), and
ethanol (Km=1.412 mM), which is due to the inactivation and denaturation of protein in organic solvents.
It is well known that proteins can esily denatured upon exposure to organic solvents due to aggregation or
the disruption of intra non covalent interactions (e.g. H2 bonds that stabilises the tertiary structure of
proteins). Because of the change of protein structure, the substrate cannot fit in and bind with the catalytic
active center of Cyt c as efficient as before. However, the K m of Cyt c@Tb-mesoMOF is as low as 0.274
mM in ethanol, and 0.403 mM in methanol respectively, which indicated excellent affinity of Cyt c@TbmesoMOF towards THB substrates in organic solvents. These kinetic results revealed that as the soild
support, the mesoporous MOF matrix protected and stabilized the immobilized protein in organic solvent
and facilitated to retain their catalytic activities. In a brief summary, the results of the measure of the
catalytic efficiency exhibits excellent perfomance of Cyt c@Tb-mesoMOF (kcat/Km =8.350 in ethanol, and
kcat/Km=5.053 in methanol) various slovents, while the free Cyt c lose its activity due to denaturation in
organic solvents (kcat/Km =3.269 in ethanol, and kcat/Km=1.193 in methanol). The catalytic efficiency
(kcat/Km value) of Cyt c@Tb-mesoMOF is ~2.6 times and ~4.3 times higher than free Cyt c in ethanol and
in methanol respectively.
The oxidation of DTBC was conducted in methanol solution due to its poor solubility in buffer. Similar
to the oxidation reaction of ABTS in ethanol or methanol, kinetic results revealed enhanced stability and
boosted catalytic activity of Cyt c upon enpasulation in Tb-mesoMOF (Table 2.5 c). With 3 times higher
affinity towards DTBC compare to free Cyt c, the catalytic efficiency (kcat/Km =26.57) of Cyt c@TbmesoMOF is ~5.2 times higher than free Cyt c (kcat/Km =5.139) in methanol.
Table 2.5a Kinetic results of catalysis of ABTS oxidation in the present of 10mM H 2O2 in pH6 MES buffer.

Free Cyt c in buffer
Cyt c@Tb-mesoMOF in buffer

-1

Vmax(mM/min)

Km(mM)

kcat(min )

kcat/Km

0.0041
0.0384

0.062
0.393

0.630
0.695

10.12
1.703
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Table 2.5b Kinetic results of catalysis of THB oxidation in the present of 10mM H2O2 in different solvants.

Free Cyt c in buffer
Cyt c@Tb-mesoMOF in buffer
Free cyto c in ethanol
Cyt c@Tb-mesoMOF in ethanol
Free cyto c in methanol
Cyt c@Tb-mesoMOF in methanol

-1

Vmax(mM/min)

Km (mM)

kcat(min )

kcat/Km

0.044
0.241
0.024
0.108
0.012
0.097

0.484
0.476
1.412
0.274
1.860
0.403

8.301
4.822
4.615
2.254
2.222
2.021

17.153
10.126
3.269
8.350
1.193
5.053

Table 2.5c Kinetic results of catalysis of DTBC oxidation in the present of 10mM H 2O2 in methanol.

Free Cyt c in methanol
Cyt c@Tb-mesoMOF in methanol

-1

Vmax(mM/min)

Km(mM)

kcat(min )

kcat/Km

0.0123
0.2393

0.4569
0.1356

2.364
3.603

5.139
26.57

To evaluate the reusability of Cyt c@Tb-mesoMOF, the catalytic cycles was conducted for both Cyt
c@Tb-mesoMOF and its mesoporous silica counterpart Cyt c@MCM-41. The results revealed that Cyt c
immobilized in Tb-mesoMOF can retain its catalytic activity for more than 11 cycles (Figure 2.26a),
while Cyt c@MCM-41 significantly lose its activity after only four cycles (Figure 2.26b). The poor
reusability of Cyt c@MCM-41is mostly attributed to severe leaching of Cyt c during the catalytic cycles.

(a)

(b)

Figure 2.25 (a) Initial THB oxidation profile catalyzed by Cyt c@Tb-mesoMOF (0.054 mM Cyt c equivalent). The
concentrations of THB range from 0.5 to 10 mM. (b) Michaelis− Menten curve fit for the THB oxidation catalyzed by Cyt
c@Tb-mesoMOF.
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(a)

(b)

Figure 2.26 Catalytic cycles of (a) Cyt c@Tb-mesoMOF (b)Cyt c@MCM-41.

2.4.4 Conclusion
A well characterized hemoprotein, cytochrome c, has been sucssesfully encapsulated into TbmesoMOF, and demonstrated excellent peroxidase activity in various solutions, including organic solvent,
such as methanol and enthanol. The Cyt c@mesoMOF demonstrated similar size selectivity to the
Mb@Tb-mesoMOF system, which further confirmed the hierarchical pore in Tb-mesoMOF enable the
size selectivity of biocatalysis upon the enpasulation of enzymes.The kinetic studies revealed enhanced
enzyme stability and boosted enzyme activity upon enpasulation in organic solvent towards various
substrates. The mesoporous MOF matix can serve as excellent solid support for biocatalysis to provide
unprecedented size-seletive function, protect and stabilize the protein from denaturation under exposure
to organic solvents.
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CHAPTER THREE: MECHANISTIC STUDIES OF
BIOMOLECULES@mesoMOF

Note to Reader
Portions of this chapter have been previously published in J. Am. Chem. Soc., 2012, 134: 13188-13191,
and have been reproduced with permission from ACS.

3.1 Investigation of Cytochrome c Translocation into a MOF Consisting of
Mesoporous Cages with Microporous Windows

3.1.1 Introduction
Protein transport is an essential mechanism in living cells.1 For protein translocation into organelles
such as mitochondria,2 endoplasmic reticulum,3 and chloroplasts,4 the proteins are typically transported
through protein-conducting channels comprising nanopores smaller than the dimensions of the protein. 5
Thus, in order for the protein to enter the organelle it must undergo significant conformational changes
during the translocation process.6 The biological mechanism associated with protein transport through
membranes suggest a mechanism through which proteins can also be transported through porous solid
state materials including metal-organic frame-works (MOFs), a new type of functional materials with
uniform nanopores.
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MOFs are highly crystalline inorganic-organic hybrids that are constructed by assembling metal ions or
metal-containing clusters with multidentate organic ligands via coordinate bonds.7 These materials feature
structural diversity and amenability to be designed with specific functionality. 8 Their tunable but uniform
pore sizes and functionalizable pore walls allow for the available nanospace to accommodate a variety of
guest species for applications in gas storage/separation,9 catalysis,10 sensing,11 drug delivery,12 etc. A
relatively unexplored aspect of MOF based materials is the potential to utilize the associated nanopores to
encapulsulate large biomolecules.13 Encapsulation of biomolecules into MOF nanopores post
synthetically, would require a protein transport process similar to that utilized for import into cellular
organelles. Thus, MOFs provide an exciting opportunity to probe the mechanistic details of protein pore
migration.
In last chapter, I demonstrated the successful immobilization of the microperoxidase-11 (MP-11) into a
MOF.14 Although MP-11 is a “micro-enzyme” with relatively small molecular dimension, this study
provided a proof of concept for the immobilization of larger proteins into the MOF interior. In this project,
I encapsulated the heme protein cytochrome c (Cyt c) in a nanoporous MOF despite the much larger
molecular dimension of the protein relative to the pore sizes of the MOF. The data presented further
indicate that the Cyt c molecules transport into the MOF through the narrow nanopores by undergoing
conformational changes, reminiscent of the process of protein translocation into some organelles via the
small nanopores.

Figure 3.1 (a) Molecular structure of cytochrome c (PDB ID 1OCD); (b) 3.9 nm-diameter cage and 4.7 nm-diameter cage
interconnected through 1.3 and 1.7 nm windows in Tb-mesoMOF.
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Cyt c is a relatively small structurally robust heme protein with a molecular dimension of ~ 2.6 × 3.2 ×
3.3 nm, and serves as a component of the electron transport chain in mitochondria as well as being
involved as a signal associated withapoptosis.15 The protein consists of a single polypeptide chain of 104
amino acid residues containing a covalently attached heme group. (Figure 3.1a).16 Considering the
framework stability in buffer solutions, the Tb-mesoMOF provides an excellent platform through which
to investigate the interaction between Cyt c and the nanopores of the Tb-mesoMOF. Crystallographically,
Tb-mesoMOF consists of nanoscopic cages of 3.9 and 4.7 nm in diameter (Figure 3.1b),17 that are
interconnected through five and six-member ring pores, which, considering van der

aals radii, have free

diameters of 1.3 and 1.7 nm, respectively. Considering the dimensions of the Cyt c molecule as well as
the hydrophobic property of Tb-mesoMOF framework, Cyt c import into the MOF interior would require
the protein to undergo a change in conformation initiated first by surface contacts between the protein and
the MOF crystal. Migration of the protein through the relatively small nanopores to enter the 3.9 and 4.7
nm-diameter cages would require a partial unfolding of the proteins tertiary structure.

3.1.2 Experimental Section
(i) Materials Syntheses
Crystalline samples of the Tb-mesoMOF were prepared according to the procedures: Tb(NO3)3⋅5H2O
(0.030 g, 6.90 x 10-5 mol) and 4,4’,4”-s-trizaine-2,4,6-triyltribenzoic acid, H3TATB (0.010 g, 2.27 x 10-5
mol) was dissolved in a DMA/MeOH/H2O (2.0 / 0.4 / 0.1 mL) in a 20 mL vial at ambient temperature.
The reaction mixture in a capped vial was heated in an oven at 105 ºC for 2 days. Colorless truncated
octahedral crystals were obtained with the yield of 44.6 % based on the 1.0 mol of H3TATB.
(ii) Cytochrome c uptake experiments
Typically 2.5 mg/mL of cytochrome c (Cyt c) from bovine heart (Sigma) was prepared in 2.0 mL 4-(2hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer (pH7.5) added into 5.0 mg of TbmesoMOF and incubated at 37°C for 75 hours. The protein concentration in the supernatant was
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determined at different time points using the BCA method of protein determination (Bicinchoninic Acid
protein assay using bovine serum albumin as the standard) in order to establish the uptake of Cyt c.18
(iii) N2 sorption measurements
N2 sorption isotherms of Tb-mesoMOF and Cyt c@Tb-mesMOF were collected using the surface area
analyzer ASAP-2020. Before the measurements, the freshly prepared samples were thoroughly solventexchanged with methanol, and activated under dynamic vacuum first at room temperature overnight and
then at 120 °C for two hours. The surface area of Tb-mesoMOF is comparable with that reported in ref.
17 for the sample activated at 80 °C.
(iv) ICP-MS and AA experiments
To quantify the amount of Cyt c protein in the MOF crystals, Cyt c@Tb-mesoMOF was dissolved by
the mixture of perchloric acid (Acros organics), H2O2 (RICCA Chemistry) and DMA (EMD), and then
diluted by DI water to the proper concentration for each test. Inductively coupled plasma-mass
spectrometry (ICP-MS) was performed on a Perkin Elmer Elan II DRC instrument to determine the
content of Fe and Tb in the sample, which was further measured by Atomic Adsorption Spectroscopy
(Varian AA Spectr 100). Both ICP-MS and AA experiments revealed the Cyt c uptake amount of ~9.8
µmol/g, which is in good agreement with the loading amount determined by BCA method.
(v) Fluorescent Spectroscopy Experiments
Steady state emission studies of Cyt c@Tb-mesoMOF were performed using samples of the solid
material (5 mg) suspended in 2 mL of an aqueous buffered solution (50 mM HEPES, pH 7.5) in a 1 cm
quartz optical cuvette using an ISS PC1 spectrofluorimeter. The sample was continuously stirred during
the measurements. Solution emission studies of Cyt c (50 mM HEPES, pH 7.5) and Cyt c in GdnHCl (50
mM HEPES, pH 7.5 + 6 M GdnHCl) were obtained using ~ 5μM protein in 2 mL of buffer. The
excitation wavelength for all studies was 280 nm with a 0.5 mm slit width on both the excitation and
emission monochrometers to minimize scatter. The Tb-mesoMOF crystals did not exhibit significant
emission in the 290-400 nm spectra region.
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3.1.3 Result and Discussion
To explore the possibility of Cyt c immobilization within Tb-mesoMOF, freshly prepared TbmesoMOF crystals were immersed in a solution of Cyt c (bovine heart) solubilized in 4-(2-hydroxyethyl)1-piperazineethanesulfonic acid (HEPES) buffer, and placed in an incubator at 37 °C. The uptake of Cyt c
by Tb-mesoMOF at different time points was determined by using the BCA method for protein
determination.19 The Cyt c Tb-mesoMOF sample (hereafter denoted Cyt c@Tb-mesoMOF) was then
washed with fresh buffer solution until the supernatant became colorless to fully remove loosely abound
Cyt c molecules. As shown in Figure 3.2a, a saturated loading of ~10.2 µmol/g was reached after ~45
hours. The successful immobilization of Cyt c into Tb-mesoMOF was confirmed by crystal optical
images and UV-Vis spectroscopy. The Tb-mesoMOF crystals became distinctly colored after being
saturated with Cyt c (Figure 3.2b), which strongly indicates the association of Cyt c molecules with TbmesoMOF. Solid-state UV-Vis absorption spectroscopy studies revealed that Cyt c@Tb-mesoMOF
exhibited a Soret band at ~410 nm, which is consistent with the Soret band of ~406 nm for Cyt c in buffer
solution (Figure 3.2c). Fracturing the crystal, revealed that the crystal interior also displayed the color of
the heme macrocycle (Figure 3.3), indicating diffusion of Cyt c molecules into the interior pores of the
Tb-mesoMOF crystal (i.e., as the heme is covalently attached to the protein, any indication of the
presence of heme also indicates the protein is present as well). Powder XRD confirmed the integrity of
MOF framework after the encapsulation of Cyt c (Figure 3.4a). N2 sorption isotherms (Figure 3.2d)
measured at 77 K indicated that the BET surface area of Tb-mesoMOF decreases from 1935 m2/g to 348
m2/g after association with Cyt c, furhter supporting the successful immobilzation of Cyt c into TbmesoMOF interior cavities.
The successful immobilization of Cyt c into the interior of the Tb-mesoMOF demonstrates that the
protein must undergo a conformational change which reduces the overall dimension of the protein
allowing for migration through the open pores at the crystal surface. Steady state fluorescence
spectroscopy provides a convenient method for determining conformational changes within a protein. In
66

the case of Cyt c the polypeptide chain contains a single tryptophan residue (Trp59) and four tyrosine
residues (Tyr48, 67, 74 and 97) that contribute to the fluorescence spectrum of the protein. 20 The Trp59
residue is located ~5 Å from the heme edge and the emission is highly quenched in the folded protein.

Figure 3.2 (a) Uptake profile of Cyt c for Tb-mesoMOF in HEPES buffer at 37 °C; (b) Optical images of Tb-mesoMOF and Cyt
c@Tb-mesoMOF; (c) UV-Vis absorption spectra for Cyt c@Tb-mesoMOF (black) and free Cyt c in HEPES buffer solution (red);
(d) N2 sorption isotherms of Tb-mesoMOF and Cyt c@Tb-mesoMOF.

Figure 3.3 Optical images of Cyt c@Tb-mesoMOF cystal before (a) and after (b) fraturing.
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(a)

(b)
Figure 3.4 (a) PXRD patterns of Tb-mesoMOF and Cyt c@Tb-mesoMOF.(b) Thermogravimetric analysis (TGA) plots of TbmesoMOF and Cyt c@Tb-mesoMOF.

The steady state emission spectra of Cyt c in buffered solution (50 mM phosphate, pH 7.5), Cyt c in
buffer containing 6 M guanidine HCl (GdnHCl), and Cyt c@Tb-mesoMOF are displayed in Figure 3.5a.
As discussed above, the spectrum of Cyt c in buffer is nearly completely quenched by the heme group.
Upon unfolding of the protein in GdnHCl emission maxima centered at 303 nm and 353 nm are observed
(with nearly equal intensity), corresponding to solvent exposed Tyr and Trp residues, respectively, that
are much farther from the heme group. Interestingly, the Cyt c@Tb-mesoMOF displays an emission
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spectrum with a maximum at ~ 353 nm and a lower intensity band centered at ~307 nm (I303 nm/I353 nm =
1 for Cyt c in GdnHCl and 0.6 for the Cyt c@Tb-mesoMOF) . These results indicate that the protein
located within the Tb-mesoMOF interior exists in a non-native conformation that is distinct from that of
the GdnHCl unfolded protein.
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Figure 3.5 Fluorescence spectra of (a) Cyt c in HEPES buffer, denatured Cyt c (by GdnHCl) and Cyt c @Tb-mesoMOF and (b)
the Cyt c@Tb-mesoMOF after different incubation times. (c) Tb-mesoMOF, TATB ligand and Cyt c@Tb-mesoMOF in HEPES
buffer.

Figure 3.5b displays the progression of fluorescence changes associated with confinement of the Cyt c
within the Tb-mesoMOF. At early times the fluorescence spectra resemble that of the GdnHCl denatured
protein but with a progressively red-shifted Trp fluorescence maximum. These data are consistent with a
mechanism for Cyt c translocation into Tb-mesoMOF (Figure 3.6) in which Cyt c molecules first adsorb
onto the surface of the MOF crystals. The surface adsorbed protein partially unfolds exposing the more
hydrophobic interior allowing for a favorable orientation for migration through the exterior pore (Scheme
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1a). At longer incubation times, the conformation and orientational alignment allow the Cyt c molecules
to enter the MOF through the relatively small nanopores (Figure 3.6). Entry of the protein into the
hydrophobic interior cavities of the MOF results in a new protein conformation exhibiting a distinct
fluorescence signature (Figure 3.6c and d). The conformation of the encapsulated protein most likely
contains water molecules solvating hydrophilic amino acids normally solvated on the proteins exterior
with amino acids forming the interior of the protein interacting with the hydrophobic walls of the interior
cavities. The color of the Cyt c@Tb-mesoMOF fractured crystals indicates that the encapsulated protein
likely retains a six coordinate and low spin heme-c macrocycle.

Figure 3.6 Proposed mechanism for Cyt c translocation into Tb-mesoMOF (red square represent the heme center).

3.1.4 Conclusion
In summary, the heme protein Cyt c was for the first time demonstrated to enter the interior cavities of
a MOF with relatively smaller pore sizes than the molecular dimension of Cyt c. Results of fluorescent
studies further suggest that Cyt c undergoes conformational changes during the immobilization process,
and adopts a conformation that is distinct from either its native conformation or that of the GdnHCl
denatured protein. A protein transport mechanism is proposed that contains the salient features of protein
translocation into cellular organelles. This work lays a foundation for employing MOFs as new type of
platforms for protein translocation studies.
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3.2 Raman Studies on the Interactions between Biomolecules and the MOF
Frameworks upon Encapsulation
3.2.1 Introduction
Enzymes are known to be the most sophisticated catalysts designed by nature due to their high
efficiency, high stereo-, chemo-, and regioselectivity as environment-friendly catalysts. Compared with
traditional (chemical) catalysis, enzymatic catalysis is generally more environmentally friendly and
features shorted synthetic routes. These merits have prompted the persistent exploration of employing
enzymes for chemical, pharmaceutical, and food industries.21,22 Nevertheless, the industrial application of
enzymes in those fields is usually hampered by their low operational stability, difficult recovery, and lack
of reusability21b,22a,23 This necessitates the development of materials and methods that can effectively
stabilize enzymes in what is often an unnatural environment while retaining their functions and activities,
and immobilizing enzymes on solid supports presents the advantages of enhanced stability as well as ease
of separation and facile recovery for reuse.24 Among various types of host matrix materials for enzyme
immobilization, mesoporous silica materials have been mostly investigated,25 but they often suffer from
leaching of the immobilized enzyme during the reaction process, which in return results in loss of activity
upon reuse.
I have demonstrated the successful encapsulation of a series of heme based biomolecules into
mesoporous MOFs, and the enzyme@mesoMOF materials exhibited superiority in enzymatic catalysis
compared to the mesoporous silica materials counterparts.14,26 The biocatalytic studies indicated that
biomolecules can be retained inside the mesoMOF for a long period of time without leaching, whereas
severe leaching was observed for mesoporous silica materials. Then the question is: why doesn’t enzyme
leach out from MOF but from mesoporous silica material? I speculate that the ability of MOF to retain
enzyme should be due to that the organic components of the framework could provide some strong
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interactions with the enzyme molecules, whereas the lack of specific interactions between the enzyme
molecules and mesoporous silica materials could account for the escape of enzyme from the support.
To unveil the interactions between enzyme molecules and mesoMOF framework, herein, the Raman
spectroscopic studies has been conducted on the MP-11@Tb-mesoMOF and Cyt c@Tb-mesoMOF
systems (Figure 3.7) that I previously developed, which not only exhibited superior enzymatic catalysis
performances compared to the mesoporous silica counterpart but also could hold the enzyme molecules
without leaching during catalytic assays. These mechanistic studies are fundamentally important because
they will provide insightful information regarding how the mesoMOFs can stabilize enzymes and/or boost
their activities in the heterogeneous catalytic systems, which will help to design new functional
mesoMOFs for enzyme immobilization with enhanced biocatalysis performances.

Figure 3.7 (a) MP-11 encapsulated into Tb-mesoMOF. (b) Cytochrome c encapsulated into Tb-mesoMOF.

Raman spectroscopy, as one of the most important vibrational spectroscopies, has been widely used for
various fields due to its advantages such as non-destructive, quick sample preparation and simple data
analysis.27 The Raman studies on chemical compounds allow for both quantitative and qualitative analysis
of the chemical structures, and have been extensively applied to study intermolecular interactions of
various biomolecules including complicated systems involving cancer cells, hemoglobin, and hormones. 8
It was also demonstrated to successfully investigate the reaction mechanism and dynamic in
hemoproteins,28c,29 and detect molecules adsorbed on porous materials.29 Recently, Raman spectroscopy
has been utilized to study gas molecules adsorbed in MOFs,30 and the success of those studies encouraged
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us to employ this tool to investigate the interactions between biomolecules and MOF frameworks. TbmesoMOF represents an excellent platform for enzyme immobilization because of its water stability and
mesoporous cage structure.17 It is formed by the coordination of Tb ions and a trigonal-planar ligand,
TATB (4,4’,4’’-s-triazine-2,4,6-triyl-tribenzoate) and exhibits a zeolite-like network with two types of
nanoscopic cages of 3.9 nm and 4.7 nm in diameters. In this project, I employed Raman spectroscopy to
unravel how biomolecules, such as MP-11 and Cyt c interact strongly with the mesoporous MOF of TbmesoMOF thus to avoid the leaching from the MOF, as in striking contrast with the mesoporous silica
material of MCM-41.

3.2.2 Experimental section

(i) Imobilization of biomolecules
Typically, for the immobilization of MP-11 into Tb-mesoMOF, 5.0 mg of Tb-mesoMOF was immersed
into 0.6 mL MP-11 (223µM) aqueous solution and incubated at 37°C until saturation (~50hours). The
MP-11 concentration in the supernatant was determined at different time points using the JASCO V-670
UV Spectrometer (λmax = 400, ε=176 mM-1cm-1) in order to track the uptake profile. For the
encapsulation of MP-11 into MCM-41 (5.0 mg), the same procedure and conditions were followed except
an initial MP-11 concentration of 4mM and incubation time of 97 hours to achieve saturation. For each
preparation, a sample of the initial MP-11 solution was also incubated under the same conditions and was
used to determine the reference concentrations and spectra. The saturated samples were then washed with
fresh pH 7.5 HEPES buffer solution (0.1 M) several times till the supernatant became colorless to fully
remove the surface adsorbed MP-11. In order to load detectable MP-11 into MCM-41 for Raman studies,
the concentration of MP-11 used during the preparation for MCM-41 is 18 times higher than that for TbmesoMOF, however, the loading amount of MP-11@MCM-41 was still relatively low (~5.4µmol/g)
compared to MP-11@Tb-mesoMOF (~20µmol/g).
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For the encapsulation of Cyt c into Tb-mesoMOF, typically 2.5 mg/mL of cytochrome c (Cyt c) from
bovine heart (Sigma) was prepared in 2.0 mL 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) buffer added into 5.0 mg of Tb-mesoMOF and incubated at 37°C for 75 hours(~10.8µmol/g).
The protein concentration in the supernatant was determined at different time points using the BCA
method of protein determination (Bicinchoninic Acid protein assay using bovine serum albumin as the
standard) in order to establish the uptake of Cyt c. The encapsulationof Cyt c into MCM-41 followed
similar procesure.
(ii) Raman spectroscopy measurements
All the Raman experiments were carried out using Confocal Raman Microscope purchased from
Horiba Jovin Yvon, equipped with an Argon and Krypton laser (Coherent, Innova 70C series). A laser at
514 nm was used with a power of 78 mW at room temperature. All samples were placed in a HEPES
buffer solution during Raman measurements. Three accumulations were employed to all samples. The
spectrograph grating was 600 grooves/mm and a 20X objective was used. In order to obtain optimal
intensities of the samples, different exposure times were applied: 5 s for buffer solution and TbmesoMOF, 10 s for MP-11@Tb-mesoMOF, 15 s for MP-11 sample, 30 s for MP-11@MCM-41,7 s for
Cyt c@Tb-MOF, 10 s for Cytochrome c sample. All experiments have been repeated at least three times
to check the reproducibility. Raman spectra in the range from 200 to 3600 cm-1 were collected and only
the region with interesting peaks was shown and discussed here. In this project, all the samples were
tested in pH 7.5 HEPES buffer, therefore, the effect of solvation in HEPES buffer on the vibrational
modes were taken into consideration.

3.2.3 Results and Discussion

Before measuring MP-11@Tb-mesoMOF and MP-11@MCM-41, the Raman spectra of HEPES buffer
(red) and MP-11 dissolved in HEPES buffer (black) were collected between 400 and 1800 cm-1. As
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shown in Figure 3.8, strong Raman bands belonging to the buffer solution were observed in the spectrum
of MP-11 solution. In addition, the fingerprint vibrational modes of MP-11 can be clearly identified at
1172 cm-1 (ν30 of heme), 1317 cm-1(ν21 of heme), 1374 cm-1 (ν4 of heme), 1567 cm-1 (ν19 of heme), 1596
cm-1(ν37 of heme), and 1644 cm-1 (ν10 of heme). respectively.29b,31
Figure 3.9 shows the Raman spectra of MP-11@Tb-mesoMOF, Tb-mesoMOF and MP-11 in the pH
7.5 HEPES buffer. It is notable that since confocal Raman microscopy was used during the measurements,
the laser was focused on the MP-11@Tb-mesoMOF crystal at the bottom of cuvette. Therefore, even
though the MP-11@mesoMOF and Tb-mesoMOF crystal was presenting in the HEPES buffer, only little
amount of HEPES solution is within the focus volume of the laser. Thus, no strong signal was observed
from HEPES buffer. It can be clearly seen that the Raman spectrum of MP-11@Tb-mesoMOF exhibits
the characteristic bands from both MP-11 and Tb-mesoMOF, indicating the presence of MP-11 in TbmesoMOF. For example, the peak at 1371 cm-1 (dotted line in Figure 3.9a) assigned to the ν4 (C-N) of
heme of MP-11 was observed in the spectra of both MP-11 and MP-11@Tb-mesoMOF. Interestingly,
significant energy shifts of Raman bands of MP-11 were found in MP-11@Tb-mesoMOF. As shown in
Figure 3.9b, the six vibrational bands of MP-11 at 1172 cm-1, 1317 cm-1, 1374 cm-1, 1567 cm-1, 1596 cm-1,
and 1644 cm-1 were red shifted to 1167 cm-1, 1311 cm-1, 1371 cm-1, 1556 cm-1, 1577 cm-1, and 1636 cm-1
respectively for MP-11@Tb-mesoMOF. The red shift of the last two peaks at 1577 and 1636 cm-1 was
observed previously 32 and is due to the disruption of the dimer or oligomer structure of MP-11 in its high
concentration when encapsulated into the pores. This, together with that the dimensions of MP-11 is ca.
3.3 × 1.7 ×1.1 nm and the sizes of two types of cages in Tb-mesoMOF are 3.9 nm and 4.7 nm, suggests
that only the monomer form of MP-11 should be accommodated within Tb-mesoMOF. The red shifts
observed for other four peaks that are associated with the vibrational modes of the heme structure in MP11 suggest that MP-11 molecules interact strongly with the framework of Tb-mesoMOF through either
the heme moieties.
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Figure 3.8 Raman spectra of 30 μM MP-11 dissolved in HEPES buffer (black) and the HEPES buffer solution (red).

In addition, obvious energy shifts of Raman bands of Tb-mesoMOF were also observed with the
presence of MP-11 within its pores as shown in Figure 3.9c. It’s worth noting that a strong new band
appears at 756 cm-1 in the Raman spectrum of MP-11@Tb-mesoMOF that is not observed in either MP11 or Tb-mesoMOF, suggesting a ferrous state (Fe2+) for iron in the heme of MP-11.29c The four
vibrational bands of Tb-mesoMOF at 993 cm-1, 1057 cm-1, 1414 cm-1 and 1613 cm-1 are red shifted to
990, 1054, 1409, and 1610 cm-1 respectively for MP-11@Tb-mesoMOF. The Raman bands at 993 and
1414 cm-1 of Tb-mesoMOF originate from the vibration of triazine of TATB,33 and the band at 1613 cm-1
of Tb-mesoMOF is assigned to C=C stretching mode of benzene ring of TATB ligand. 34 It is noteworthy
that the band at 1414 cm-1 associated with the vibration of triazine of TATB undergoes a large shift of 5
cm-1; whereas in the case of MP-11 (Figure 3.9b), largest band shift is observed in the peaks at 1317 cm-1
(a shift of 6 cm-1) and 1567 cm-1 (a shift of 11 cm-1), which are assigned to C-H and C=C of heme respectively.32 This thus suggests that the triazine in the TATB ligand of Tb-mesoMOF interact strongly
with heme moities in MP-11.
These Raman spectroscopic data support a mechanism for MP-11 immobilized inside Tb-mesoMOF
(Figure 3.10) in which there is strong π···π interactions between the conjugated systems (including
triazine and benzene rings) of TATB organic ligand in Tb-mesoMOF and the heme of MP-11. These
strong interactions facilitate the retention of MP-11 molecules inside the cages of the MOFs framework.
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Figure 3.9 (a) Raman spectra of MP-11@Tb-mesoMOF (black), Tb-mesoMOF (red), and 30 μM MP-11 in HEPES buffer
solution (blue). (b) Magnified images of Raman band shifts between MP-11 and MP-11@Tb-mesoMOF and (c) between TbmesoMOF and MP-11@Tb-mesoMOF.
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Figure 3.10 Tentative mechanism for the specific interactions between MP-11 and Tb-mesoMOF.

The Raman spectrum for MP-11@MCM-41 was also measured. MP-11@MCM-41 experienced
severe leaching during catalytic assays. Figure 3.11 shows the Raman spectra of MP-11 and MP11@MCM-41. Despite high concentration of MP-11 used during the immobilization process, the Raman
signal of MP-11 encapsulated in MCM-41 is much weaker than in Tb-mesoMOF. This agrees well with
the observation that MCM-41 has a much lower loading capacity of MP-11 compared to Tb-mesoMOF.
Two peaks at 1559 and 1636 cm-1 that are associated with MP-11 are observed for MP-11@MCM-41,
confirming the presence of MP-11 in MCM-41. Interestingly, Raman shift was observed only for the peak
at 1640 cm-1 with a red shift of 4 cm-1, which was also observed for MP-11@Tb-mesoMOF and is due to
the disruption of the dimer or oligomer structure of MP-11. No additional peak shift was observed for all
other bands. These data suggests that there is no strong specific interaction between MP-11 and MCM-41,
which should account for the severe leaching of MP-11 during and after its immobilization into MCM-41
(Figure 3.12).

Figure 3.11 Raman spectra of MP-11@MCM-41 (black) and 0.8 mM MP-11 in HEPES buffer solution (red).
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Figure 3.12 UV-Vis spectrum of the supernatant for MP-11@MCM-41 assay indicating severe leaching of MP-11.

Figure 3.13 shows Raman spectra of pH 7.5 HEPES buffer solution and Cyt c in the buffer in a range
from 400 to 1800 cm-1. It is clear that the Raman spectrum of Cyt c solution contains vibrational bands
belonging to the HEPES buffer as well as fingerprint of Cyt c. As the arrows pointed out, many
characteristic peaks of Cyt c were observed and their peak assignment can be found in previous study.35
For example, the vibrational modes at 1130, 1175 and 1365 cm-1 are due to the vibrations of half ring of
pyrroles. The bands at 1231 and 1314 cm-1 are from deformations of Cm-H. The band at 1401 cm-1 is
from vibration of quarter-rings of pyrroles. The band at 1550 cm-1 is due to vibration of CβCβ while the
bands at 1585 and 1637 cm-1 are from vibration of CαCm.36-38 Among the many Raman peaks of Cyt c, the
presence of Raman bands at 751 and 1365 cm-1 indicates Cyt c is in ferrous (Fe2+) state of the heme.35
Figure 3.14 (a) shows the Raman spectra of Cyt c@Tb-mesoMOF, Tb-mesoMOF, and Cyt c in pH 7.5
HEPES solution. The Raman spectrum of Cyt c@Tb-mesoMOF displays the characteristic bands from
both Cyt c and Tb-mesoMOF which indicates the presence of both in the complex. For example, the
strongest band of Tb-mesoMOF at 1613 cm-1, attributed to C=C stretching mode of the benzene ring of
Tb-mesoMOF,35 was also the strongest one in the spectrum of Cyt c@Tb-mesoMOF complex at the same
peak position.
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Figure 3.13 Raman spectra of 25 μM Cyt c (red) dissolved in 0.1 M HEPES buffer solution and the HEPES buffer solution
(Blue).

More importantly, energy shifts of the Raman band of Cyt c@Tb-mesoMOF were observed compared
with those of either Cyt c or Tb-mesoMOF. In detail, two vibrational bands of Cyt c at 751 and 1550 cm1

were observed to blue shift to 759 and 1556 cm-1 in the spectrum of Cyt c@Tb-mesoMOF. The band at

751 cm-1 arises from breathing mode of pyrrole rings while the band at 1550 cm-1 is due to vibration of
CβCβ. The shifts indicate that the pyrrole rings are involved when Cyt c interacts with Tb-mesoMOF. In
contrast, red shifts were observed between Tb-mesoMOF and Cyt c@Tb-mesoMOF. As shown in Figure
3.14(c), two Raman bands at 407 and 493 cm-1 of Cyt c@Tb-mesoMOF were observed to red-shifted
from the bands of Tb-mesoMOF at 412 and 498 cm-1, respectively. These bands are due to C-C-C torsion
of benzoic acid of TATB ligand of Tb-mesoMOF.39 Interestingly, there was no energy change observed
for the strongest band of Tb-MOF at 1613 cm-1 assigned to C=C stretching mode of the benzene ring of
the benzoic acid of TATB ligand. Thus, Cyt c residing into the cages of Tb-mesoMOF may prefer to
interact with the part close to carboxyl group of benzoic acid instead of the ring itself of the TbmesoMOF.
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Figure 3.14 Raman spectra of (a) Cyt c@Tb-mesoMOF, Tb-mesoMOF, and Cyt c containing pH7.5 HEPES buffer solution. (b)
Magnified images of Raman band shifts between Cyt c and Cyt c@Tb-mesoMOF and (c) between Tb-mesoMOF and Cyt c@TbmesoMOF.

3.2.4 Conclusion
In summary, the interactions between enzyme and MOF have been unveiled via Raman spectroscopic
studies on MP-11@Tb-mesoMOF and Cyt c@Tb-mesoMOF. In MP-11@Tb-mesoMOF system, MP-11
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molecule interacts with the framework of Tb-mesoMOF through π•••π interactions between the heme of
MP-11 and the conjugated triazine and benzene rings in the organic ligand of Tb-mesoMOF. The strong
interaction facilitate the retention of MP-11 molecules within the MOF pores, whereas the lack of specific
interactions between MP-11 and the silica material of MCM-41 as also revealed by Raman spectroscopic
studies accounts for the severe leaching of MP-11 from MCM-41. The Raman studies on Cyt c@TbmesoMOF confirmed the encapsulation of Cytochrome c in the pores of Tb-mesoMOF. Upon
encapsulation, two Raman bands belonging to Cyt c were observed to blue shift while two vibrational
modes of Tb-mesoMOF red shifted. Those shifts of vibrational modes of both Cyt c and Tb-mesoMOF
upon encapsulation indicates strong interaction between the two components and possibly between the
pyrrole ring parts of Cyt c and benzoic acid part of Tb-mesoMOF. This work thus provides the in-depth
understanding of the behavior of enzyme in solid state host matrix materials, and will be instructive for
the design of new functional MOFs for enzyme immobilization to enhance enzyme stability and boost
enzyme activity.

3.3 Vitamin@Tb-mesoMOF: Raman and Diffusion Studies of Vitamins in
Mesoporous Metal-Organic Frameworks

3.3.1 Introduction
The understanding of the mechanisms associated with the transport phenomena for biomolecules in
biological systems are not only essential to research advances related to cell and molecular biology,
physiology, immunology, and biochemistry, but also contribute to applications such as drug and gene
delivery,40 biological transduction,41 as well as the design and operation of devices, such as biosensors,42
kidney dialysis43 and high density cell culture.44 Moreover, along with the dramatic development of
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formulation, drug delivery45,46 and biocatalysis,23,47 the understanding of transport phenomena of
biomolecules in porous systems becomes an attractive and significant topic.
Metal–organic frameworks (MOFs) have emerged as an important family of porous materials with
potential for various applications,48 including gas separation and storage,49 catalysis,50 sensors51 and
biomedical applications.52 MOFs can exhibit cavities and/or open channels with a range of pore sizes
from micro- to mesoporous. Their structural versatility together with amenability to be designed with
specific functionality as well as extra-large surface areas confer them a special place amongst traditional
porous materials.53 In particular, that ligands can be designed with particular organic functional groups for
specific interactions with biomolecules makes them attractive to stabilize biomolecules such as proteins
or vitamins for bio-related applications.14,26,54 More importantly, the beauty of metal-organic frameworks
is their completely ordered crystalline structure and easy characterization by various techniques, which
entitle mesoporous MOFs an attractive platform for the investigation of the transportation phenomena of
biomolecules in porous systems.
Before the further development and application of a novel porous material, the understanding of its
kinetic diffusion and other transport phenomena is essential. The diffusion kinetic of zeolites, 55
mesoporous silica materials56 and some other nanoparticles57 etc. has been investigated and thus provide
valuable guidance for their various applications. However, to the best of our knowledge, the transport
phenomena and kinetic details for the encapsulation and releasing of biomolecules into MOFs mostly
remain unexplored,58 and most of the kinetic studies related to MOFs focus on the diffusion of gas
molecules.59 Particularly, there is rarely molecular mechanisms supported by mathematical models and
experimental evidence in this field, which is a tremendous barrier to be overcomed for the future
applications of this group of promising materials.
Generally, B vitamins are essencial to cell metabolism, especially to the process of the conversion of
proteins and other nutritions into energy. Some of the B vitamins, such as folate, vitamin B12, and vitamin
B6 participate in one-carbon metabolism.60 Deficiencies of B vitamins may cause severe impairment of
brain function and coronary heart dieases, and it is also reported to be related to Alzheimer disease. 61
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Although the solubility is different from one to another, all the B vitamins are water-soluble, and any
excess is excreted in the urine, meaning that there is usually no storage of B vitamins in body. Therefore,
most of the B vitamins must be replenished regularly. Although congenictal defects or severe deficiencies
of B vitamins are rare, mild vitamin deficiencies are not uncommon in the elderly.With the characterized
UV-vis adsorption and proper molecular dimentions (1.41×1.83×1.14 nm for vitamin B12 and
1.45×1.31×0.57 nm for vitamin B2, Figure 3.15), vitamin B12 and vitamin B2 are both favorable probes for
biomolecule transportation studies, and thus frequently utilized for the detection of the membrane
permeability of capsules or drug delivery studies.62 As an important component of several enzymes,
vitamin B12 (cobalamin) is essential to the metabolism of certain amino acid and various cell growth and
development process. Vitamin B2 (Riboflavin) forms the central component of coenzyme flavin
mononucleotide (FMN) and flavin adenine dinucleotide (FAD) in body and also plays important roles in
metabolism and energy production. 63

Figure 3.15 The wire-stick models of (left) vitamin B12 and (right) vitamin B2, Color scheme: C, brown; H, white; O, red; N,
blue; P, purple; Co, cyan.

In this project, I tried to address the dearth of the machenistic study for biomolecule transportation
phenomena in mesoporous systems. The vitamin B12 and B2 biomoledules was successfully encapsulated
into mesoporous MOFs and characterized by different approaches. Raman studies were conducted to
investigate the specific interactions between the vitamin molecules and mesoporous MOF frameworks. A
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mechanistic study was also conducted based on the mathematical expression of the principles of transport
processes to further investigate the diffusion of those biomolecules into mesoporous systems. This study
provides a novel platform for the investigation of transport phenomena of biomolecules in porous systems
and also opens a new avenue for the vitamin encapsulation and control releasing. A mesoporous MOF,
Tb-mesoMOF was employed as host matrix for exploration on vitamin encapsulation and releasing,
considering its water stability and nanoscopic cages. Tb-mesoMOF exhibts a MTN zeotype structure with
two nanoscopic cages possessing appoximately sphare internal spaces of 3.9 and 4.7 nm in diameter for S
and L cages repectively. The S cage is surrounded by 12 pentagonal windows with a window size of ~1.3
nm; while the L cage is surrounded by 12 pentagonal and 4 hexagonal windows of ~1.7 nm (Figure
3.16).17 Since mesoporous silica materials have been widely investigated for encapsulation of active
molecules for biocatalysis64,65 and prolonged drug delivery for decades,66 a mesoporous silica material,
MCM-41 has also been involved for comparison purpose.67

Figure 3.16 (a) MTN topology of Tb-mesoMOF with two different cages indicated in blue for S cage (right, 3.9nm) and pink for
L cage (left, 4.7 nm); (b) space-filling models of Tb-mesoMOF with nanoscopic cages, Color scheme: C, gray; O, red; N, blue;
Tb, turquoise.

3.3.2 Experimental section
(i) General Information.
All reagents were purchased from Fisher Scientific or SigmaAldrich Co., Inc. and used without further
purification. The water solvent was purified by ELGA Flex 3 water purification system. UV spectra were
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measured on a JASCO V-670 UV/Vis/NIR Spectrometer. Surface areas were measured on an ASAP 2020
surface area and pore size analyzer under N2 77K. Optical images of the crystals were taken by Olympus
MIC-D camera. The Raman experiments were carried out using a Confocal Raman Microscopy
(Olympus, IX71) purchased from Horiba JovinYvon, equipped with an Argon and Krypton laser
(Coherent, Innova 70C series).
(ii) Material synthesis.
Crystalline samples of the mesoporous MOF, Tb-mesoMOF was prepared according to the procedures
described in charpter 2. The mesoporous silica MCM-41 was purchased from Sigma-Aldrich Co., Inc.
(iii)Encapsulation of vitamins.
Typically, 5.0 mg of Tb-mesoMOF was immersed into 1.0 mL vitamin B12 (3 mg/mL) or vitamin B2
(~0.1 mg/mL) aqueous solution and incubated at 37°C. The vitamin concentration in the supernatant was
determined at different time points using the JASCO V-670 UV Spectrometer (λ = 361 nm and 444 nm
for vitamin B12 and vitamin B2 respectively)68 in order to track the uptake profile. The molar absorption
coefficient at the maximum absorbance at 361 nm of vitamin B12 is 26500 L mol-1 cm-1, 69and at 440 nm
of vitamin B2 is 12160 L mol-1 cm-1.70 For the encapsulation of vitamins into MCM-41 (5.0 mg), the same
procedure and conditions were followed. For each preparation, a sample of the vitamin solution was also
incubated under the same conditions and was used to determine the reference concentrations.
(iv) N2 sorption measurements.
N2 sorption isotherms of Tb-mesoMOF and vitamin@Tb-mesoMOF were collected by the surface area
analyzer ASAP-2020. Before the measurements, the freshly prepared samples were thoroughly solventexchanged with methanol, and activated under dynamic vacuum first at room temperature overnight and
then at 120 oC for two hours. The surface area of Tb-mesoMOF is comparable with that reported in ref.
17 for the sample activated at 80 oC.
(v) Raman spectroscopy.
All the Raman experiments were carried out using a Confocal Raman Microscopy (Olympus, IX71)
purchased from Horiba JovinYvon, equipped with an Argon and Krypton laser (Coherent, Innova 70C
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series) producing a laser with the wavelength at 514 nm and 647 nm. In case of studying interaction
between Tb-mesoMOF and vitamin B12, an excitation laser with the wavelength at 514 nm was applied
with 40 mW of power, 5 s of exposure time and 3 accumulations. To study the interaction between
MCM-41 and vitamin B 12, an excitation laser with wavelength at 647 nm was applied with 20 mW of
power, 10 s of exposure time and 5 accumulations.The reasons for using different laser wavelength is that
MCM-41 suffers from fluorescence background interference when the laser at 514 nm is used. The
spectrum grating was 600 grooves/mm and an objective of 20X was used for both applications.

3.3.3 Result and Discussion
To explore the encapsulation of vitamin molecules into mesoporous MOFs, freshly prepared TbmesoMOF crystals were immersed in a certain concentration of vitamin B12 or B2 solution, and then
placed in an incubator at 37 °C. Based on the concentration change of the supernatant at different time
points determined by the UV-vis spectra, the Tb-mesoMOF uptake of vitamin B12 reached its saturation
after ~27 hours with a loading of ~ 0.33 mg vitamin B12 /mg Tb-mesoMOF (Figure 3.17a). In terms of
vitamin B2, due to the poorer water solubility, the vitamin B2 stock solution was relative diluted (~0.1
mg/mL), however, as a remarkable molecular `sponge', after being immersed into the vitamin B2 solusion
for less than 7 hours, Tb-mesoMOF bleached out all the vitamin B2 molecules in the stock solution(Figure
3.17b). It is notable that even if the concentration of the vitamin in the solution was low, the active
molecules could be loaded with high efficiency in Tb-mesoMOF compare to mesoporous silica. For both
vitamin B12 and vitamin B2, the loading capacity of MCM-41 is significantly lower than Tb-mesoMOF
presumably due to the relative low surface area (BET surface area: ∼1000 m2/g), pore volume and smaller
pore size (Figure 3.18). 67
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(a)

(b)

Figure 3.17 (a) The uptake profile of vitamin B12 into Tb-mesoMOF(black) and into MCM-41(red); (b) The uptake profile of
vitamin B2 into Tb-mesoMOF(black) and into MCM-41(red).

Figure 3.18 N2 sorption isotherms of MCM-41(left); Pore size distribution of MCM-41(right).

To fully remove the vitamin molecules on the crystals surface of Tb-mesoMOF, the vitamin saturated
Tb-mesoMOF sample (hereafter denoted VB2@Tb-mesoMOF and VB12@Tb-mesoMOF) was quickly
washed with water multiple times until the supernatant became colorless. After being saturated with
vitamin B2, the color of Tb-mesoMOF crystals turned brown whereas the color turned dark red with
saturation of vitamin B12 (Figure 3.19a), which indicates the ingress of vitamin molecules into TbmesoMOF. In addition, UV-Vis Spectroscopy and gas adsorption methods were also used to confirm the
sucessful encapsulation of vitamin molecules into Tb-mesoMOF. Solid-state UV-Vis absorption
spectroscopy studies revealed that VB12@Tb-mesoMOF exhibited a strong absorption at ~364 nm which
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represented a slight bathochromic shift compared to the band of ~361 nm for vitamin B12 (Figure 3.19b).
Similar to vitamin B12, the encapsulation of vitamin B2 into Tb-mesoMOF also lead to the shift of UV
peak center from ~444nm to ~451nm (figure 3.19c), indicating the interactions between the trapped
vitamin molecules and the framework of Tb-mesoMOF.71 N2 sorption isotherms (Figure 3.20) measured
at 77 K indicated that the Langmuir surface area of Tb-mesoMOF significantly decreased from 3247 m2/g
to 235 m2/g after association with vitamin B2, further supporting the successful immobilzation of vitamin
B2 into Tb-mesoMOF interior cavities. Furthermore, the N2 sorption isotherm showed no significant
surface area (~50 m2/g) after the saturation of vitamin B12, indication of blockage of the pores by vitamin
B12 in VB12@Tb-mesoMOF.

(a)

(b)

(c)

Figure 3.19 (a) Optical images of Tb-mesoMOF(top), VB2@Tb-mesoMOF(bottom left) and VB12@Tb-mesoMOF(bottom right) ;
(b) UV-Vis absorption spectra for VB12@Tb-mesoMOF (black) and VB12 (red). (c) UV-Vis absorption spectra for VB2@TbmesoMOF (black) and VB2 (red).

Figure 3.20 (a) N2 sorption isotherms of Tb-mesoMOF and VB12@Tb-mesoMOF(left); (b) N2 sorption isotherms of TbmesoMOF and VB2@Tb-mesoMOF(right).
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Vitamin releasing from Tb-mesoMOF and MCM-41 was tracked by UV-vis spectrophotometer at
361nm for vitamin B12 and 440nm for vitamin B2. As depicted in Figure 3.21a, Tb-mesoMOF can
progressively release vitamin B12 for ~250 hours, and it took even longer time to fully release vitamin B2
from Tb-mesoMOF (~300 hours, Figure 3.21b). However, a 100% releasing from MCM-41 was achieved
after only ~70 hours for vitamin B12 (Figure 3.21a) and ~110 hours for vitamin B2 (Figure 3.21b). Another
notable observation is that the initial releasing rate for both vitamins from MCM-41 is significantly higher
than Tb-mesoMOF, and this kind of “burst release” (release of an initial large bolus of drugs before the
release rate reaches a stable profile), in terms of drug delivery systems, could be pharmacologically
dangerous and economically inefficient.72 Several situations may occur to justify the observed dfferences:
Firstly, it is important to point out that the significant “burst effect” has been only observed in the case of
MCM-41 that possesses lower surface area, pore volume and smaller pore size. Thus, it indicates the
external surface adsorption of vitamin on MCM-41. As vitamin molecules were located mostly at the
surface, it further explained the low loading capacity of MCM-41.73 Additionally, unlike MCM-41, TbmesoMOF possesses the mesoporous cages with relative small microporous windows (1.3 and 1.7 nm
windows for the S and L cages respectively, Figure 3.16), which causes steric hindrance for the releasing
of the active molecules. For example, the small windows of the cages promoted the chance for the
encapsulated vitamin molecule to hit the “dead ends” and get banced back and forth to find its way out,
which leads to the delay of the releasing time.58b Furthermore, the nanoscopic cavities of Tb-mesoMOF
can also create the relative local richness of the active molecules, so when the vitamin molecules pass
through the mesopores into the solution, the immobilized molecules inside the mesopore can create steric
hindrance of the motile ones.74 The relative “crowded” molecular environment can also enhance the
interactions between the functionalized mesoporous structure and the guest molecules in the relative
confined space.75 Therefore, the interaction between the pore walls of Tb-mesoMOF and vitamin
molecules may also contribute to the continuous releasing. Indeed, compare to silica materials, the
mesopores in MOFs possess the organic ligand with aromatic rings, which is favorable for π-π interaction;
and the metallic centers in the formula unit provide possible Lewis acid sites. The adaptive internal
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microenvironment of the cavities in the frameworks could probably interpret the exceptional
encapsulation and control release performance of Tb-mesoMOFs.

(a)

(b)

Figure 3.21 (a) The releasing profile of vitamin B12 into Tb-mesoMOF (black) and into MCM-41(red); (b) The releasing profile
of vitamin B2 into Tb-mesoMOF (black) and into MCM-41(red).

Raman spectroscopy is the vibrational spectroscopic method that opened up variety of possible
applications to different scientific fields.76-79 One of the many promising applications of Raman
spectroscopy is that it provides fine detail information of molecular structure and interaction between
molecules. It has also been used to reveal the interaction between molecule of interest and a matrix. 80-82
The interactions between vitamin B12 and organic metallic or inorganic frameworks, Tb-mesoMOF or
MCM-41, were successfully characterized by Raman spectroscopy. Figure 3.22 shows the Raman spectra
of Tb-mesoMOF (red), vitamin B12 solution (blue) and VB12@Tb-mesoMOF (green). Characteristic peaks
of Tb-mesoMOF were observed in the spectra of Tb-mesoMOF with and without vitamin B12
encapsulation. As indicated by the solid lines in Figure 6, the peak at 1447 cm-1 is assigned to the C-O
stretching of benzoic acid structure and the peak at 3089 cm-1 is assigned to the C-H stretching mode in
Tb-mesoMOF.39 Not surprisingly, the energy of both peaks remains the same before and after vitamin B12
encapsulation indicating that these vibrational modes are not affected when vitamin B12 is in the TbmesoMOF framework. On the other hand, as illustrated by the dotted lines in Figure 3.22, there are also
peaks specific of vitamin B12 presenting in both spectra of vitamin B12 before and after being encapsulated
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in Tb-mesoMOF. For example, the strongest peak of vitamin B12 at 1496 cm-1 belonging to the in-phase
stretching vibration of the Corrin π system83,84 exhibits exactly the same energy in solution and in TbmesoMOF, also shown in Figure 3.23 (C). Also, there is no change observed for all peaks of vitamin B12
above 2000 cm-1 in the hydrogen-involving vibrational region when vitamin B12 is in the Tb-mesoMOF.
These identical peaks in both spectra with exactly same energy prove the successful encapsulation of
vitamin B12 in Tb-mesoMOF. Further comparison of the three spectra in detail provides information about
possible interaction between Tb-mesoMOF and vitamin B12. Figure 3.23 shows the magnified Raman
spectra zoomed in from Figure 3.22 in different ranges. In Figure 3.23 (A) from 600 cm-1 to 650 cm-1 of
spectrum range, the peak at 627 cm-1 is involved with the deformation of the pyrroline rings and possible
bending modes of the corrin ring.83 Interestingly, when vitamin B12 is encapsulated in Tb-mesoMOF, blue
peak shift were observed: the peak at 627 cm-1 is shifted to 630 cm-1. This peak is believed to shift from
vitamin B12 since the slight duplex form of peak 630 cm-1 in vitamin B12 encapsulated Tb-mesoMOF
spectrum is identical to the peak at 627 cm-1 in vitamin B12. The energy shift of this peak indicates that
such vibrational modes are involved when vitamin B12 is encapsulated in the Tb-mesoMOF. As the
stretching mode of the corrin ring at 1496 cm-1 does not exhibit any shift, it is suggested that vtamin B12
interacts with the Tb-mesoMOF framework through the pyrroline ring structure.

Figure 3.22 Raman spectra of Tb-mesoMOF (red), Vitamin B12 (3 mg/mL aqueous solution, (blue) and VB12@ Tb-mesoMOF
(green)
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Figure 3.23 Raman spectra of Tb-mesoMOF (red), vitamin B12 (blue) and VB12 @Tb-mesoMOF (green) in different range.

Figure 3.23B shows the change of three peaks belonging to Tb-mesoMOF upon encapsulation of
vitamin B12. The three peaks, 993 cm-1, 1020 cm-1 and 1057 cm-1, all red shifted by 8 or 6 cm-1 upon
vitamin B12 insertion indicating strong interaction between vitamin B12 and Tb-mesoMOF. Among those
three peaks, the strongest shift is observed on the one at 993 cm-1, which belongs to the C-N stretching
vibration of triazine of TATB.85 The peak at 1057 cm-1 is assigned to the wagging mode of triazine
structure while the peak at 1020 cm-1 belongs to the in-plane deformation of the benzoic ring structure.39
In Figure 3.23C, the peak of Tb-mesoMOF shift from 1612 cm-1 to 1607cm-1 upon encapsulation of
vitamin B12, which belongs to C=C stretching mode of benzene ring of TATB ligand.34 Clearly, the
triazine and benzoic ring structure of Tb-mesoMOF might serve as the active site when interacting with
vitamin B12.
Figure 3.24 shows the Raman spectra of vitamin B12 (green), MCM 41 (red) and VB12@MCM-41
(blue). The peak at 978 cm-1 assigned to terminal silanol group of MCM-41, as indicated by a dotted line,
is observed in the spectra of both MCM-41 and VB12@MCM-41. This is the only available peak to
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indentify the presence of MCM-41.86,87 Many peaks of vitamin B12, as indicated by the solid lines are
observed in the spectra of both vitamin B12 and VB12@MCM-41. This proves that vitamin B12 can be
successfully placed inside of the MCM-41. Interestingly, detailed examination of the spectra reveals that
there is no peak shift, not a single one, of either vitamin B12 or MCM-41 when vitmain B12 is
encapsulated in the silica framework. This observation indicates that there is no strong interaction
between vitamin B12 and MCM-41. Such a conclusion agrees well with the fact that vitamin B12 can easily
be released from the MCM-41 after only one or two days.

Figure 3.24 Raman spectra of MCM 41 (red), vitamin B12 (3 mg/mL aqueous solution, green) and VB12@MCM 41 (blue).

The interaction between vitamin B2 (VB2) and Tb-mesoMOF or MCM-41 was also examined by
Raman spectroscopy. However, VB2 does not provide significant Raman signals due to high fluorescence
background. In fact, there is no Raman information reported so far about VB 2; therefore, it is not
discussed in this paper.
To study the kinetics of the diffusion of biomolecules into mesoporous MOFs, the initial rate of
vitamin uptake, the diffusion rate, and the coefficient of diffusion for the 2-phase system consisting of TbmesoMOF and vitamin B12 solution was calculated based on the uptake data at 37 °C (Figure 3.17) that
has been collected. The equation for the best-fit line of the uptake curve is shown below:
F(x)=-0.0034x2+0.1086x+0.1063 (1)

Where x is the incubation time in hours.
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Given the best-fit line calculated, it is possible to determine both the initial rate of the reaction and the
reaction rate at any given point. The initial rate of the reaction can be calculated by taking the 1st
derivative of the equation (1) at one of the initial data points (since this is when the plot is the most
linear.) By fitting the uptake curve for vitamin B12 into Tb-mesoMOF, the uptake initial rate was
calculated to be 0.088 mM/hour while the reaction rate after 7 hours of incubation is much lower (0.060
mM/hour), meaning the uptake rate is increasing at a decreasing rate. Moreover, the calculated values
were very close to the experimental data.
The diffusion coefficient was calculated based on the following formula, which is designed for the
diffusion from a well-mixed bath into a sphere of radius R88,89.
∑

(

( )

)

The equation is written in dimensionless form through the use of Laplace transforms. The variable in
this equation are defined as follows:
,

Where

, and

is the concentration of the vitamin solution at time t; C0 is the initial concentration of the

vitamin B12 solution, Vf is the volume of the solution; Vb is the volume of Tb-mesoMOF; Deff is the
diffusion coefficient of the solution; R is the radius of the crystal structure. The partition coefficient Φ
was assumed to be 1.88,89 The equation (2) was rewritten as follows:
⁄
( )

)

∑

⁄

(

is the solution to the equation,

To solve for

(

, the formula was rearranged as follows:
( )
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In order to determine the different values of λi, the zeroes of the equation (which are not asymptotes)
are located. Figure 3.25 below shows the different values for
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Figure 3.25 The different values of
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Table 3.1 Summary of the different values for
equation.

(when i=1-7). These were the

which were used to test each data point in the

Value of i
3.614
6.585

1
2
3

9.640

4

12.733

5

15.842

6

18.962

7

22.088

The graph of ( ) was constructed (see Figure 3.25), and the zeroes of the equation (which are not
asymptotes) were located to determine different values of
approaches
(

)

infinity,

the

expression

)

(

(see SI for different values of
approaches

to

negative

). As i

infinity,

and

approaches to zero. Therefore, it can be deduced that the infinite sum converges at zero when
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the system is at equilibrium, at which

=

. In this experiment, we assumed that the concentration

after 19.3 hours of incubation (1.3 mM) to be the concentration at equilibrium. The resulting equation to
solve for

is as follows:

From this equation,

was calculated to be equal to 1.398, and the diffusion coefficient was determined

by substituting the value of

and different values of

s to approximate the value of the infinite sum. The

following procedures outline the calculation of the diffusion coefficient using the data collected after 3
hours of incubation.
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were used because the values of the following terms were very small, and therefore

negligible. Through several attempts of approximation, the best value for the diffusion coefficient was
determined to be 43 nm2/hr. The accuracy of the calculated diffusion coefficient was also checked with
the data obtained from the uptake experiment. For example, after the fifth hour of incubation, the
concentration of the vitamin solution was 1.66 mM. The calculation is shown below.
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∑
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The calculated value of the infinite sum on the right side of the equation was 0.172, which is relatively
close to the value obtained experimentally on the left side, which was 0.161. Therefore, the obtained
value for the diffusion coefficient is deemed to be accurate.
To give a perspective, the diffusion coefficient obtained from our calculation with Tb-mesoMOF was
compared with several different binary diffusion coefficients for biological systems. For example,

97

diffusion coefficients for the diffusion of proteins into liquids range from 2.778 nm2/hour to 19.444
nm2/hour and proteins into tissues are from 0.194 nm2/hour to 2.778 nm2/hour.88 It turned out that the
diffusion coefficient of our system (43 nm2/hr) was significant larger than those biological systems, which
indicated the fast transportation of biomolecules into mesoporous MOF.

3.3.4 Conclusion
In conclusion, I demonstrated here for the first time that mesoporous MOF can be used as a novel
platform for the study of transport phenomina of biomolecules in the porous systems. Vitamin B12 and
vitamin B2 has been successfully encapsulated into a mesoporous MOF, Tb-mesoMOF. Vitamin@TbmesoMOF has been characterized by Solid state UV-vis, N2 gas sorption, and optical images. The Raman
study of vitamin B12, Tb-mesoMOF and VB12@Tb-mesoMOF further confirmed the encapsulation of
vitamin B12 in the pores of Tb-mesoMOF. More importantly, the shift of vibrational modes of both
vitamin B12 and Tb-mesoMOF upon encapsulation indicates that there are strong interactions between the
two components and possibly between the pyrroline structure of vitamin B12 and the triazine and benzoic
rings of Tb-mesoMOF. The kinetics of the diffusion of biomolecules into Tb-mesoMOFs has also been
investigated. The initial uptake rate for vitamin B12 encapsulation was be 0.088 mM/hour, and the
diffusion coefficient was found to be 43 nm2/hr. Herein I propose that this novel system provides an
exciting opportunity to probe the mechanistic details of the transport phenomena of biomolecules into
mesoporous systems.
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CHAPTER FOUR: BIOMIMETIC CATALYSIS OF METAL-ORGANIC
FRAMEWORKS

Note to Reader
Portions of this chapter have been previously published in Inorg. Chem., 2012, 51, 12600-12602, and
have been reproduced with permission from ACS Publishing.

4.1 Biomimetic catalysis of a porous Fe-based metal-metalloporphyrin
framework

4.1.1 Introduction

Enzymes are known to be among the most conspicuous materials in terms of catalysis due to their
hallmarks such as high affinities towards substrates, substantial rate accelerations relative to uncatalyzed
reactions, and unrivaled catalytic efficiency based on the high stereo-, chemo-, and regioselectivity.1,2
However, the high cost, highly restricted reaction conditions, and the fragile nature of enzymes hinder
their industrial applications.3-6 One of the big challenges lays in how to successfully stabilize enzymes in
what is often an unnatural environment while retaining their functions and activities. As one of the
approaches that have been widely investigated to surmount these problems, enzyme immobilization can
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improve the thermal and environmental stability of enzymes and insolubilize them for easy recovery and
recycling.6-9 The solid supports (e.g. microporous zeolite, mesoporous metal oxide and silica,
macroporous polymers and metal-organic frameworks (MOFs)) often broaden the applicable pH range of
enzymes, and protect them from denaturing by organic solvents, high temperature or autolysis. Just as in
all other fields of scientific research, a lot of innovations in catalysis can be inspired by nature. Generally,
biomimetic catalysis refers to chemical catalysis that mimics certain key features of enzymes. 10-12
Biomimetic catalysts offer new perspectives and promising approaches to avoid those barriers, and
provide opportunities for the design of materials to overcome the handicap of enzymes while retaining
their beneficial features. Biomimetic catalysis is an important constitution of biomimetic chemistry,
which is also encompassed by bio-inspired self-assembly of small molecules and biomimetic reactions in
the total synthesis of natural products. By imitating the structural features and mechanisms of enzymes,
biomimetic strategies can be used to develop catalysts with high turnover rates, efficiency and specificity,
while also having enhanced robustness that is easy to prepare and apply.13,14 Biomimetic catalysts can
often survive in various solvents (e.g. H2O, buffer, methanol, ethanol, and dichloromethane and
dimethylformide) and harsh conditions (e.g. relative strong acid or base, high temperature, various
organic solvent) with enhanced stability in comparison with their enzyme counterparts. In addition,
biomimetic catalysts sometimes exhibit catalytic selectivities that are not observed in the native enzymes.
Enzymes are capable to catalyze myriad reactions, from the most fundamental reactions like simple
oxidations of straight chain alkanes to reactions as complicated as C–C bond formation with exceptional
selectivity. Some of the challenging transformations in organic synthesis can be easily achieved by
enzymatic catalysis under mild conditions. By mimicking the active sites of native enzymes, many
powerful catalysts can be generated for the synthesis and modification of fine chemicals and complicated
drug molecules. In addition, with the continuous inspiration from nature, biomimetic catalysts can often
be operated under mild and environmental-friendly conditions with the reduction of energy consumption,
waste generation and greenhouse gas emissions, and thus goes with the tendency of Green Chemistry. 1,2
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Compared with traditional chemical catalysis, the knowledge in enzymatic catalysis is still relatively
limited. The studies in biomimetic catalysis provide the platforms for improved understanding of the
mechanism and kinetic of enzymes. This fundamental understanding will in turn facilitate the design of
biomimetic materials. In addition, biomimetic strategies can also provide guidance in the development of
compounds (eg. drugs or prodrugs) containing enzymatic structural motifs to catalyze reactions of
biological interest.
In terms of the uniformity, the biomimetic catalysts can be divided into two catalogs: homogeneous or
heterogeneous systems. Heterogeneous systems can offer great advantages in comparison with the
homogeneous counterparts. One of the primary advantages of heterogeneous biomimetic catalysis is that
the catalyst can be effectively recovered in straightforward manners, such as filtration, and such easy
recovery and recycling is of paramount importance for large-scale industrial and commercial
manufacturing processes. Moreover, the solid support improves the dispersion of the catalytic active sites
and thus enhances the catalytic efficiency. These features are of particular importance with regard to
expensive catalyst, such as enzymes and precious metals. The facile separation of catalyst can minimize
or eliminate catalyst contamination and thereby lead to higher purity of the product, which will
significantly reduce the cost of purification process.
Several analogs of materials have been widely investigated for biomimetic catalysis, such as organic
macrocycles, polymers, nanoparticles, porous aluminosilicates and mesoporous silicas,11-14 among which
the porous polymer, aluminosilicates and silicas have been used as the support for the design of
heterogeneous biomimetic catalysts. However, those traditional porous materials are composed of either
inorganic or organic compounds and suffer from intrinsic limitations. Specifically, the inorganic
compounds lack structural flexibility, whereas the organic compounds are usually amorphous without
crystalline structure. MOFs, which are defined as the 2D or 3D coordination polymers composed of metal
moieties and organic linkers, have fueled intensive research over the past two decades in a variety of
fields, such as gas separation and storage, heterogeneous catalysis, biocatalysis, sensors and
biomedicine.15 As an emerging family of highly porous crystalline materials, MOFs can be deliberately
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designed to combine the beneficial properties of organic and inorganic materials into one system by preselecting the appropriate inorganic (metals or metal clusters) and organic (organic ligands) building
blocks and/or by post-synthetic modifications, and thus largely expand the repertoire of porous materials.
The unlimited choices of metals and organic building blocks give rise to enormous structural diversity yet
various metrics and functionalities. Therefore, MOFs possess several extraordinary properties that are
preferred for the design of biomimetic catalysts, such as high surface area (up to 10,000 m2/g ), high and
tunable porosity, structural versatility as well as the amenability to be designed with specific
functionality, and thus position them a unique place amongst traditional porous materials. Moreover,
MOFs can be tailored to create the proper environment around the catalytically active site, which can
associate with the cages/channels of MOFs to demonstrate chemo-, regio-, stereo- and/or
enantioselectivities that cannot be expected from native enzymes. In addition, since the crystal structures
of MOFs is more accessible than other porous materials, the pore environments in MOFs are clearer than
ever before. The well-defined shape, size, and chemical environments of the cages or channels of MOFs
offer excellent opportunities to design and control the morphology, composition, distribution of the
catalytically active site and the porous support, which will give rise to the improvements in catalytic
performance and understanding of the basis of heterogeneous biomimetic design. Last but not least, these
heterogeneous biomimetic catalysts can be created from a range of methodologies such as one-pot
synthesis, post-synthetic modification, ship-into-a-bottle strategies, etc., and the different strategies used
for the biomimetic design can also affect the catalytic performance of the catalysts.
However, although the first biomimetic strategy reported in MOF applications can be dated back to as
early as 2006,16 the biomimetic catalysis based on MOFs has rarely been explored, and the design and
application of MOF-based biomimetic catalysts has yet to be systematically and comprehensively
developed. Herein, the strategies for the design and synthesis of MOF-based biomimetic catalysts,
especially the structural features of representative MOFs related to biomimetic catalysis are reviewed.
Recent advances of biomimetic catalysis of MOFs and the relationship between their catalytic
performances and the structural specificities are discussed in details as well.
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Despite the tremendous progress achieved in the biomimetic field, the research of artificial enzymatic
catalysis is still in its infancy. In a natural enzymatic system, the structure of the enzyme is elaborately
constructed to precisely control the function. This fine-tuning between the structure and function leads to
the excellent catalytic efficiency. Therefore, the performance of biomimetic catalysts can rarely keep up
with their natural enzyme counterparts due to the low structural tunability and complexity. A solution to
this problem may be offered by emerging of MOFs, which can be fine-tuned and tailored to create the
proper environment around the catalytic active site. For less than one decade, the biomimetic catalyst
toolbox was further broadened by MOF-based catalysts.
In terms of the design of MOF-based biomimetic catalysts, several critical factors need to be taken
into cautious consideration for both types of biomimetic catalysts, such as 1) the diffusion of
substrates/products, 2) the dispersion of catalytic active sites and 3) the affinity of biomimetic catalyst
towards certain substrates. Generally, the diffusion of the reactant to the catalyst surface can often be the
rate-limiting step in heterogeneous catalysis. In order to initialize the catalysis, the substrate has to diffuse
into the framework and interact with the catalytic active sites embedded in the MOF structures. Therefore,
the quick diffusion of substrates into the framework will accelerate the catalytic process, and is crucial for
the high initial rate and catalytic efficiency. On the other hand, the products need to diffuse out of the
framework, so the removal of the products from the framework will change the chemical equilibrium and
facilitate to precede the reaction in the forward direction. In addition, the accessible space of the
biomimetic catalyst will potentially limit the number of available active sites, which will also affect the
reaction rates. Therefore, high porosity, high surface area, and large pore sizes are favorable for the
design of MOF-based biomimetic catalysts. In this context, mesoporous MOFs (mesoMOFs) can largely
expanded the utility of MOFs on catalysis due to their enlarged pore sizes (2-50nm) as well as the special
characteristics of the mesoporous cages or channels, such as the shape and chemical environments. Some
beneficial features of MOFs such as the tunable pore sizes and high surface areas can be utilized to
improve the dispersion of catalytic active sites, and thus enhance the catalytic efficiency. The unlimited
choices of metals and organic building blocks provide the opportunity to deliberately design the MOFs
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with specific functional motifs to interact with certain substrates and improve the affinity of the
biomimetic system. In order to achieve the optimal affinity towards target substrate in a biocatalysis
system, the shape and charge distribution of the active site in enzyme is often complementary to that of
the target substrate. This feature can inspire the design of biomimetic catalysts. For example, for a
hydrophobic substrate, the hydrophobic catalytic active sites can provide favorable hydrophobic
interactions in the polar aqueous buffer, which further enhance the binding affinity. In addition, for
enzymatic reactions, the enzyme active sites usually prefer a hydrophobic environment than an aqueous
system to achieve higher initial rates. This rate acceleration is due to the fact that many mechanisms of
enzymatic catalysis are based on general acids or bases. In aqueous systems, these highly soluble reagents
need to undergo the desolvation process, so that they can interact with the substrate and catalyze the
reaction. The design of a biomimetic catalyst involving a hydrophobic pocket can provide the favorable
hydrophobic environment, and enhance the hydrophobic binding to the target substrate.
The MOFs consist of iron metal or metal cluster and ligands including porphyrins as major component
can form the metalloporphyrin motifs within the framework to mimic the heme active center of hemeenzyme in terms of both structure and reactivity, and are capable of performing peroxidation of organic
substrates by the use of hydrogen peroxide. Larsen’s group17 synthesized a class of biomimetic catalysts,
MOMzyme-1(Metal Organic Material enzyme), by selective encapsulation of catalytically active
metalloporphyrins within one of the three nanoscale cages that exist in HKUST-1 using a “ship-in-abottle” approach.18 In this approach, metalloprophyrins were encapsulated into the MOM frameworks
during the solvothermal synthesis of MOMzyme-1. Specifically, based on the different size and symmetry
of the three nanoscale cages, the metalloporphyrin was selectively encapsulated in the most suitable
octahedral cage (Figure 4.1). Moreover, the benzenesulfonic acid group of the porphyrin ligand will
further penetrate to adjacent cages and thus form the orient-specific proximal and distal heme pocket,
which is crucial for the catalytic functions associated with heme enzymes. In addition, the hierarchal
cages in MOMzyme-1 system provide multifunction: the large pores provide the host for the ingression of
metalloporphyrin, while the remaining cavities allow the diffusion of substrates and products. Up to ~66%
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(cavity) porphyrin loading can be achieved depending on the concentration of porphyrin during the
synthesis process. To evaluate the catalytic performances of this system, the peroxidase activity of
Fe4SP@HKUST-1 (one of the MOMzyme-1 catalysts) towards monooxygenation of organic substrates
was investigated using 2,2'-azinodi(3-ethylbenzthiazoline)-6-sulfonate (ABTS) as a redox indicator. This
catalytic reaction was compared with the homogenous systems, such as microperoxidase-11(MP-11),
horse heart myoglobin (hhMb), and Fe4SP. Notably, the maximum yield in this biomimetic system is
comparable to its MP-11 and Fe4SP counterpart in solution. However, due to the diffusion of the
substrate molecules into the HKUST (Cu) frameworks, in terms of initial rate, the product formation is
slower in this heterogeneous Fe4SP@HKUST-1system compared with the homogeneous systems. In
addition, Fe4SP@HKUST-1 retained ~66% of the initial catalytic activity after three recover cycles.

Figure 4.1 (Left) The geometry of 5-NPIA and the paddlewheel moieties. Green: plane of the benzene ring in 5-NPIA. Yellow:
planes of the two carboxylate moieties of 5-NPIA. (Right) Diagram illustrating the encapsulation of metalloporphyrins within the
octahemicatohedral cages of HKUST-1.

To develop porous MOFs as platforms for biomimetic catalysis, one can selectively encapsulate the
active centers of enzymes into the cavities of MOFs; or one can regularly arrange the active centers of
enzymes into MOF frameworks using the derivatives of active center molecules as struts. The later
strategy is particularly appealing to mimic heme proteins, because Fe-porphyrin that is the active center
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(Fe protoporphyrin IX) of heme proteins can be readily functionalized as struts for the construction of
MOFs.19 In continuation of our work on the development of porous metal-metalloporphyrin frameworks
(MMPFs),20 in this project, I synthesized a Fe-based MMPF, MMPF-6, which demonstrates interesting
peroxidase activity comparable to that of the heme protein myoglobin.

4.1.2 Experimental Section

(i) Synthesis of MMPF-6.
A mixture of zirconyl chloride octahydrate (20.0 mg), Fe(III) meso-tetra(4-carboxyphenyl)porphyrin
chloride (4.0 mg), dimethylforamide (DMF) (5.0 mL) and formic acid (3.0 mL) was capped in a 20 mL
scintillation vials and heated at 135 °C for 80 hours. The dark red crystals of MMPF-6 were collected by
filtration and washed with DMF. The sample can be amplified to hundreds of milligrams using multiple
vials.
(ii) Synthesis of MMPF-6 (Fr).
tetrakis(4-carboxyphenyl)porphyrin instead of Fe(III) meso-tetra(4-carboxyphenyl)porphyrin chloride
was used via the above procedure for the synthesis of free-base MMPF-6, MMPF-6(Fr).
(iii) Examination of the catalytic activities.
The initial rates for purpurogallin formation were monitored using 0.5mM 1,2,3-trihydroxybenzene
(THB) in presence of 10 mM H2O2 in HEPES buffer or ethanol by various catalysts discussed in this
work (~250µg MMPF-6 and MMPF-6(Fr) solid catalysts and 5M free Mb were used) on a JASCO V670 spectrophotometer. The oxidation of the substrate to the corresponding oxidized product
purpurogallin was directly monitored at 420 nm (ε = 2.64 mM -1cm-1) by taking the absorption spectra of
the supernatant solution at various time points over the reaction.
The initial rates for ABTS+• formation were monitored using 1mM 2,2′ azinodi(3-ethylbenzthiazoline)6-sulfonate (ABTS) in presence of 10 mM H2O2 in HEPES buffer or ethanol by various catalysts
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discussed in this work (~250µg MMPF-6 and MMPF-6(Fr) solid catalysts and 5M free Mb were used)
on a JASCO V-670 spectrophotometer. The oxidation of the substrate to the corresponding oxidized
product ABTS+• was directly monitored at 660 nm (ε = 12 mM-1cm-1) by taking the absorption spectra of
the supernatant solution at various time points over the reaction.
(iv) N2 sorption experiment.
N2 sorption isotherm of MMPF-6/MMPF-6(Fr) was collected on the surface area analyzer ASAP-2020
using a liquid nitrogen bath. Before the measurements, the freshly prepared sample was solventexchanged with acetone, and activated under dynamic vacuum at 120 oC for 48 hours. ~100 mg activated
sample was employed for the gas sorption measurement.

4.1.3 Result and Discussion

Dark red block crystals of MMPF-6 were obtaining by reacting Fe(III) meso-tetra(4carboxyphenyl)porphyrin chloride (Fe-TCPP-Cl) (Figure 4.2a) with zirconyl chloride under solvothermal
conditions. Single-crystal X-ray studies revealed that MMPF-6 has the same structure as the recently
reported MOF-545-Fe,21 in which the Fe-TCPP-Cl ligands connect with the in situ generated secondary
building units of Zr6O8(CO2)8(H2O)8 (Figure 4.2b) to form a three-dimensional (3D) structure consisting
of hexagonal and triangular 1D channels that have a diameter of ~36 and ~12 Å (atom to atom distance),
respectively (Figure 4.2c). The phase purity of the bulk sample MMPF-6 was confirmed by powder X-ray
diffraction (PXRD) studies (Figure 4.3). The permanent porosity of MMPF-6 was assessed by N2 sorption
at 77 K (Figure 4.4), which revealed a typical type IV isotherm22 and a Brunauer-Emmett-Teller (BET)
surface area of 2100 m2/g comparable to that reported in the literature.21 The pore size distribution
analysis based upon N2 adsorption data at 77 K by the use of DFT Model revealed that the pore sizes of
MMPF-6 are predominantly around 11 Å and 33 Å (Figure 4.4 insert), which are close to the channel
sizes observed crystallographically.
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Figure 4.2 (a) Fe(III) meso-tetra(4-carboxyphenyl)porphyrin chloride ligand; (b) Zr6O8(CO2)8(H2O)8 SBU; (c) hexagonal and
triangular 1D channels of MMPF-6 (Color scheme: C, grey; O, red; Cl, green; Zr, turquoise).

Figure 4.3 Powder X-ray patterns of MMPF-6 and MMPF-6(Fr).

It is well known that heme is the catalytic center for heme proteins including cytochromes, peroxidases,
myoglobins, and hemoglobins, and is capable of performing peroxidation of organic substrates by the use
of hydrogen peroxide.23 The peroxidase activity of heme proteins can be assessed with the assay of certain
substrates, such as 1,2,3-trihydroxybenzene (THB) and 2,2′ azinodi(3-ethylbenzthiazoline)-6-sulfonate
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(ABTS) by monitoring the rate of increase in absorbance at feature wavelength of the oxidation product (
660 nm for ABTS+• and 420 nm for purpurogallin) subsequent to the addition of peroxide (Figure 4.5).24
The regular arrangement of hemes (Fe(III)-porphyrin macrocycles) with the five-coordinate Fe(III)
centers orienting toward the channels in MMPF-6 prompted us to evaluate the potential peroxidase
activity of MMPF-6. The catalytic assays were conducted for MMPF-6, and compared with the heme
protein myoglobin (Mb). Mb is oxygen storage protein25 and its peroxidase activity has also been widely
studied,26 although the activity is less than that of native peroxidase.27

Figure 4.4 N2 sorption isotherms of MMPF-6 at 77 K (insert: pore size distribution based upon DFT model).
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Figure 4.5 Reaction scheme for oxidation of THB (top) and ABTS (bottom) by hydrogen peroxide catalyzed by heme-base
catalyst.

Before catalytic assays, the content of heme centers in MMPF-6 was measured to be 6.18 × 10-4 mol/g
by inductively coupled plasma mass spectrometry (ICP-MS) experiments on the activated MMPF-6
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sample. The relatively lower measured content of heme centers compared to that estimated from single
crystal x-ray crystallography derived formula (7.98 × 10-4 mol/g) should be attributed to the incomplete
removal of the high boiling point guest DMF molecules during the activation process. Free-base MMPF6, MMPF-6(Fr), was also synthesized (Figure 4.3) for control experiments. As shown in Figure 4.6a and
4.6b, without catalyst, both of the blank reaction is going very slowly with the rates of only 3.47x10-5
mM/s for THB and 2.87x10-6 mM/s for ABTS oxidation (Table 4.1) in the 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES) buffer. MMPF-6 indicates a very fast initial rate of 1.39×10-3
mM/sec for purpurogallin formation,28 which is about one third as fast as free Mb in HEPES buffer
(Figure 4.6a and Table 4.1). Moreover, MMPF-6 demonstrates impressive catalytic performance not only
for the oxidation involving oxygen transfer but also electron transfer. For ABTS oxidation, it turns out a
very fast initial rate of 8.18×10-4 mM/sec for ABTS+• formation, which is about one forth as fast as free
Mb in HEPES buffer (Figure 4.7a and Table 4.1). I reasoned that the slower initial rate for MMPF-6
compared to free Mb should originate from the diffusion of the substrates from solution into the channels
of MMPF-6. MMPF-6(Fr) have very limited catalysis for both reactions with slow initial rates (Figure
4.6a and 4.7a), which is about one fourteenth or one thirtieth as fast as MMPF-6 (Table 4.1) thus
indicating an insignificant contribution from the framework and Zr oxide cluster. No detectable leaching
of heme or iron metal in the reaction solution was observed after removal of MMPF-6 by filtration as
evidenced by virtually no activity for the filtrate solution. MMPF-6 can be reused for four cycles without
significant drop in its peroxidase activity (Table 4.1) and can also retain its framework integrity as
confirmed by PXRD studies (Figure 4.3), highlighting its heterogeneous feature.
I also assessed the peroxidase activity of MMPF-6 in organic solvents, in which heme proteins are
known to easily lose their activities.25 Catalytic assays performed in ethanol solutions indicated that
MMPF-6 demonstrated an initial rate of 4.34 × 10-4 mM/sec for purpurogallin formation and 7.56 × 10-5
mM/sec for ABTS+• formation (Figure 4.6b and 4.7b), meaning an enhancement of ~107 or ~215 times
for the reaction without catalyst (Table 4.1). In comparison, free Mb exhibited a much slower initial rate
(Table 4.1, Figure 4.6b and 4.7b) due to the agglomeration of Mb molecules in ethanol.25 Slow initial
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rates was observed for MMPF-6(Fr), furthering supporting the essential role of heme centers in MMPF-6
for the peroxidase activities.

(a)

(b)

Figure 4.6 Kinetic traces for the oxidation of THB in (a) HEPES buffer and (b) ethanol solution.

(a)

(b)

Figure 4.7 Kinetic traces for the oxidation of ABTS in (a) HEPES buffer and (b) ethanol solution.
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Table 4.1 Summary of catalysis results of oxidizing of THB and ABTS in the presence of 10 mM H2O2.

Initial rate for
Initial rate for
Initial rate for ABTS+•
Initial rate for
purpurogallin formation in purpurogallin formation formation in HEPES ABTS+• formation in
HEPES buffer (mM/sec) in ethanol (mM/sec)
buffer (mM/sec)
ethanol (mM/sec)
Blank
Free Mb

a

a

3.47×10-5

4.29×10-6

2.87×10-6

3.51×10-7

-3

-5

4.59×10

3.54× 10

-3

1.87×10-5

3.37× 10

MMPF-6

1.39×10-3

4.34×10-4

8.18×10-4

7.56×10-5

MMPF-6(Fr)

9.89×10-5

6.62×10-5

2.82×10-5

1.65×10-5

MMPF-6b

9.06×10-4

6.96×10-5

6.26×10-4

6.96×10-5

Diluted to 5 M; b The forth cycle.

4.1.4 Conclusion
In summary, a porous Fe-based metal-metalloporphyrin framework, MMPF-6 was constructed by selfassembly of the Fe(III) meso-tetra(4-carboxyphenyl)porphyrin chloride ligand with the in situ generated
Zr6O8(CO2)8(H2O)8 SBU under solvothermal conditions. MMPF-6 demonstrated interesting peroxidase
activity comparable to that of the heme protein myoglobin in terms of initial reaction rates in buffer
solutions. MMPF-6 retained the peroxidase activity in ethanol solution highlighting its adaptability for
organic solvents. This work paves a way to develop MOFs as a new type of biomimetic catalysts, and
also opens up new perspectives for mimicking heme-based proteins.
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